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SUPPLEMENTARY MATERIALS AND METHODS 
 
HUMAN STUDIES 
SAM trial: study population and study protocol 
The human study entitled ‘Development and field testing of ready-to-use therapeutic foods 
(RUTF) made of local ingredients in Bangladesh for the treatment of children with severe acute 
malnutrition’ was approved by the Ethical Review Committee at icddr,b and conducted between 
April 2013 and December 2015 (ClinicalTrials.gov identifier: NCT01889329). The goal was to 
determine whether therapeutic food prototypes made from locally available food ingredients were 
non-inferior to a standard, commercially available RUTF used for treating children with SAM 
(Plumpy’Nut; Nutriset). A total of 343 children, aged 6 to 59 months, were enrolled with SAM 
[defined as WHZ <-3, bipedal edema, and/or a mid-upper arm circumference (MUAC) <11.5 
cm]. Written informed consent was obtained from their parent or guardian. Children from urban 
or peri-urban areas of Dhaka were recruited at Dhaka Hospital of icddr,b, and from two clinics 
[Terre des Hommes (TDH) Specialized Nutritional Unit, Kurigram and Radda Maternal Child 
Health and Family Planning Center (MCH-FP), Mirpur].  
 Rehydration and antibiotic therapy were initiated for children presenting without signs or 
symptoms of infection other than those of diarrhea (34). Antibiotic treatment began with 
intramuscular or intravenous ampicillin 100 mg/kg/d with doses every 6 h, and gentamicin 5 
mg/kg/d with doses every 12 h. If there was no evidence of septicemia after 48 h, ampicillin and 
gentamicin were discontinued and amoxicillin was administered orally (100 mg/kg) every 8 h for 
3 more days. Children with pneumonia were treated with intravenous chloramphenicol (100 
mg/kg) every 6 h for 24 h and then orally for a total of 7 days. If septicemia was suspected, 
ampicillin was given (200 mg/kg/day) and gentamicin was continued for 7–10 days (34). After 
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acute stabilization, entailing rehydration and a short course of antibiotics (34), children were 
transferred for follow-up treatment to the Nutrition Rehabilitation Unit (NRU) of Dhaka Hospital, 
TDH or Radda MCH-FP.  
 An appetite test was performed prior to randomization to one of the three therapeutic food 
arms; a rice-lentil formulation, a chickpea-containing formulation (both locally produced) (35), or 
Plumpy’Nut. Therapeutic food was provided each morning at a dose of ~200 kcal/kg/d. Children 
who were breast-fed continued breastfeeding. Subjects were discharged from the study upon 
fulfillment of the following graduation criteria: (i) edema-free WHZ ≥ -2 for those admitted with 
WHZ <-3 and/or edema, or (ii) MUAC ≥ 115 mm with edema-free weight gain of 15% for those 
admitted with a MUAC < 115 mm. Before discharge, children were treated with an anti-
helminthic per national guidelines (200 mg albendazole for those aged 12-23 months; 400 mg for 
those greater than 24 months), and their parents received nutritional counseling.  
 As described in the main text and Fig. 1A, a subset of 54 children at the Dhaka Hospital site 
were enrolled in a sub-study that included regular fecal sampling and three blood draws for up to 
1 year after discharge from the NRU (n = 20, Plumpy’Nut arm; n = 19, rice-lentil based 
therapeutic food arm; n = 15, chickpea-containing therapeutic food arm). Fecal samples were 
collected and within 10 minutes were transferred to liquid nitrogen pre-charged dry shippers 
(Taylor Wharton, CX-100) for transport back to the lab where they were stored at -80oC. EDTA 
plasma was prepared from blood using standard procedures and placed in a -80 oC freezer. Coded 
biospecimens were shipped to Washington University on dry ice where they were stored at -80oC, 
along with associated clinical metadata, in a dedicated biospecimen repository with approval 
from the Washington University Human Research Protection Office. 
 
MDCF trial: study population and protocol 
Sixty-three 12-18-month-old children diagnosed with MAM (WHZ <-2) who were no longer 
exclusively breastfed were enrolled in a double-blind, randomized, four group, parallel 
assignment interventional trial study (ClinicalTrials.gov identifier NCT03084731) conducted in 
Dhaka, Bangladesh and approved by the Ethical Review Committee at icddr,b. The study was 
designed to test the effects of three locally produced MDCF prototypes described in Fig. 6A and 
a locally produced rice-lentil-based ready-to-use supplemental food (RUSF). Linear programming 
was used to design the MDCF prototypes, with a target energy density of 250 kcal/50 g, and a 
caloric distribution of 45–55 percent from fat and 8–12 percent from protein. All diets were 
supplemented with a multiple micronutrient premix that provided 70% of the recommended daily 
allowance (RDA) for vitamins A, C, D and E, all B vitamins, calcium, copper, iron, magnesium, 
manganese, phosphorous, potassium and zinc. Diets were produced daily at the Food Processing 
Laboratory of icddr,b using a standardized production procedure to insure consistent quality of 
MDCFs across batches. 
 After obtaining informed consent, socio-demographic data were collected for all participants, 
and children were randomized into one of four treatment groups (n=14-17 per group). After 2 
weeks on their home diet, with weekly fecal sample collection and anthropometry, children and 
their mothers attended a local community health clinic every morning and afternoon where each 
child was provided 25 g per feeding session of their assigned MDCF/RUSF. Mothers were asked 
not to give any food or breast milk during the 2 hours preceding the prescribed feeding session. 
The quantity of food consumed by each child was recorded at each visit. Mothers were instructed 
to continue normal breastfeeding and home-based complementary feeding practices. A blood 
sample was collected and EDTA-plasma was prepared from each child at the beginning of the 
intervention phase (week 3) and again at the end of the 4-week intervention (week 7) for targeted 
MS-based metabolomic and proteomic analyses. Fecal samples, together with anthropometric and 
morbidity data, were collected weekly from each child, including during a 2-week post-
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intervention period. A separate reference cohort of thirty 12- to 24-month-old healthy children 
(WHZ and HAZ scores > -1) were also consented to provide a single blood and fecal sample to 
compare with samples collected from the children with MAM enrolled in the intervention study. 
All biospecimens were rapidly cryopreserved after collection (see above), coded and stored at -
80oC prior to transfer to Washington University, with approval from the Washington University 
Human Research Protection Office. 
 
Targeted MS-based metabolomics analysis of plasma samples  
Clinical chemistry analytes, including plasma levels of glucose, lactate, triglycerides, total 
ketones, and non-esterified fatty acids (NEFA), were measured using a UniCel DxC600 clinical 
analyzer (Beckman). Reagents for the first three analytes were provided by Beckman (Brea, CA) 
while those for ketones and NEFA were obtained from Wako (Mountain View, CA). Amino 
acids, acylcarnitines, organic acids, and acylCoAs were analyzed using stable isotope dilution 
techniques. Amino acids and acylcarnitines were measured by flow injection tandem MS with 
specific internal standards (36,37); data were acquired using a Waters AcquityTM UPLC system 
equipped with a triple quadrupole detector and a data system controlled by MassLynx 4.1 OS 
(Waters, Milford, MA). Organic acids were quantified using Trace Ultra GC coupled to ISQ MS 
operating under Xcalibur 2.2 (Thermo Fisher Scientific) (38). AcylCoAs were extracted, purified 
and measured by flow injection analysis using positive electrospray ionization on a Xevo TQ-S 
triple quadrupole MS (Waters) (39); heptadecanoyl CoA was employed as an internal standard 
(40). 
 
Quantitative proteomics  
Plasma levels of leptin and insulin were quantified by using the MILLIPLEX MAP Human Bone 
Magnetic Bead Panel (MilliporeSigma). The human IGF-1 Quantikine ELISA (R&D Systems) 
was employed to measure IGF-1. 
 The SOMAscan 1.3K Proteomic Assay plasma/serum kit (SomaLogic, Boulder, CO, USA) 
was used to measure 1,305 proteins in plasma samples (50 μL aliquots). Following the 
manufacturer’s protocol and utilizing SOMAmer reagents immobilized on streptavidin beads, 
proteins from plasma samples were tagged with NHS-biotin reagent, captured as a SOMAmer 
reagent/protein complex, cleaved, denatured, eluted and hybridized to a custom Agilent DNA 
microarray. Microarrays were scanned with an Agilent SureScan scanner at 5 µm resolution, and 
the Cy3 fluorescence readout was quantified. Raw signal values were processed using 
Somalogic’s SOMAscan standardization procedures, including hybridization normalization, plate 
scaling, median scaling, and final SOMAmer calibration. The R package ‘limma’ (Bioconductor) 
was used to analyze differential protein abundances. In limma, signal data are subject to linear 
model fitting and empirical Bayesian statistics for group comparisons (32). Spearman correlation 
analyses were performed between measured SOMAscan analytes (proteins) and anthropometric 
scores, plasma metabolites, as well as the abundances of bacterial OTUs in fecal samples. 
 Proteins measured in the plasma of children with healthy growth phenotypes or with SAM 
(prior to treatment) were rank-ordered according to the fold-difference in their levels between 
these two groups. As noted in the main text, the top 50 most differentially abundant proteins in 
healthy compared to SAM were designated as healthy growth-discriminatory proteins, and the top 
50 most differentially abundant in SAM compared to healthy were designated as SAM-
discriminatory proteins. The average fold-change for these healthy growth- and SAM-
discriminatory proteins was then calculated for each treatment arm in the MDCF trial (pre- versus 
post- MDCF/RUSF treatment) and normalized to the mean fold-change across all four arms 
(column normalization in Fig. 6B). Limma was used to calculate statistical significance. 
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 Proteins with an absolute Pearson’s r > 0.25 and FDR corrected p-value < 0.05 for HAZ were 
identified. The average fold-change in abundance for these ‘HAZ-discriminatory proteins’ was 
calculated for each treatment arm in the MDCF trial (pre- versus post-treatment) and normalized 
to the mean fold-change across all four arms (column normalization in Fig. 6C). 
 Proteins measured by the SOMAscan were mapped to all Gene Ontology (GO) ‘Biological 
Processes’ in the GO database (www.geneontology.org). SetRank, a gene set enrichment analysis 
(GSEA) algorithm (33), was employed to identify GO ‘Biological Processes’ that were 
significantly enriched for proteins that exhibited changes in abundance from pre- to post-
treatment with MDCF/RUSF. Enrichment was calculated using the setRankAnalysis function in 
the SetRank R library (parameters: use.ranks = TRUE; setPCutoff = 0.01; and fdrCutoff = 0.05). 
The average fold-change for each protein in the statistically significant Biological Process 
category was calculated for each treatment arm and normalized to the mean fold-change across all 
four arms (Fig. 7A-C). We defined proteins within the GO Biological Process as ‘healthy growth-
discriminatory’ if they were at least 30% more abundant in healthy individuals compared to those 
with SAM, and ‘SAM-discriminatory’ if they were at least 30% more abundant in children with 
SAM compared to those who were classified as healthy.  
 
Characterizing human fecal microbial communities as a function of host nutritional status 
V4-16S rRNA gene sequencing and data analysis - Frozen fecal samples were pulverized in 
liquid nitrogen. DNA was extracted from an aliquot of the pulverized material (~50 mg) by bead-
beating with 500 µL of 0.1 mm diameter zirconia/silica beads in a solution consisting of 500 µL 
phenol:chloroform:isoamyl alcohol (25:24:1), 210 µL 20% SDS, and 500 µL buffer A (200 mM 
NaCl, 200 mM Trizma base, 20 mM EDTA). DNA was purified (Qiaquick columns, Qiagen), 
eluted in 70 µLTris-EDTA (TE) buffer, and quantified (Quant-iT dsDNA broad range kit; 
Invitrogen). Each DNA sample was adjusted to a concentration of 1 ng/µL and subjected to PCR 
using barcoded primers directed against variable region 4 of the bacterial 16S rRNA gene and the 
following cycling conditions: denaturation (94 oC for 2 minutes) followed by 26 cycles of 94 oC 
for 15 seconds, 50 oC for 30 seconds and 68 oC for 30 seconds, followed by incubation at 68 oC 
for 2 minutes (2). Amplicons were quantified, pooled and sequenced (Illumina MiSeq instrument, 
paired-end 250 nt reads). Paired-end reads (trimmed to 200 nt) were merged (FLASH, version 
1.2.6), demultiplexed, clustered into 97% ID OTUs and aligned against the GreenGenes 2013 
reference database using QIIME version 1.9.0 (41). Taxonomy was assigned to 97% ID OTUs 
with RDP 2.4, as described previously (42). The resulting OTU table was filtered to include only 
OTUs with ≥0.1% relative abundance in at least two samples.  
 As recent studies have produced newer methods for processing 16S rDNA data, a sensitivity 
analysis was performed comparing OTU assignments derived from QIIME with ASVs generated 
from DADA2. This analysis, described in (31), confirmed the concordance between the QIIME 
and DADA2 outputs.  
 Microbiota-for-age Z-scores – MAZ scores (2) were calculated using the sparse RF-derived 
Bangladeshi model of normal gut microbiota development, and the median and standard 
deviation of the predicted microbiota ages of the reference cohort of chronologically age-matched 
healthy Mirpur infants/children (binned by month).  
 Functional microbiome maturity - DNA was extracted from frozen fecal samples, quantified 
(Qubit), and each preparation was normalized to a concentration of 0.75 ng/µL. Libraries were 
generated from each DNA sample using the Nextera XT kit (Illumina) with the reaction volume 
scaled down 10-fold to 2.5 µL (43). Samples were pooled and sequenced (Illumina NextSeq 
instrument; paired-end 150 nt reads). A defined consortium of 16 human gut bacterial strains was 
included in each sequencing run as a reference control. Reads were quality filtered with Sickle 
(44) and Nextera adapter sequences were trimmed using cutadapt (45). Bowtie2 and the hG19 
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build of the H. sapiens genome were employed to identify and remove host sequences prior to 
further processing. Reads were subsequently assembled using IDBA-UD (46) and initially 
annotated with Prokka (47). Paired-end sequencing reads generated from each sample were 
mapped to contigs that had been assembled from that sample. Duplicate reads (optical- and PCR-
generated) were identified and removed from mapped data using the Picard MarkDuplicates tool 
(v 2.9.3). Counts were aggregated for each gene (featureCounts; Subread v. 1.5.3 package) (48) 
and normalized (reads per kilobase per million, RPKM) in R (v. 3.4.1) (49). 
 Functional profiles for each fecal microbiome sample were generated by assigning 
microbiome-encoded proteins to a collection of 58 mcSEED subsystems/pathway modules that 
capture core metabolism of 75 nutrients/metabolites in four major categories (19 amino acids, 10 
vitamins, 40 sugars, and 6 fermentation products) projected over 2,313 annotated reference 
bacterial genomes. The meta-proteomes from all samples were clustered at 90% identity 
[MMSeqs2 (50); --min-seq-id 0.9]. One representative protein sequence was randomly selected 
from each cluster. Clustering and representative protein sequence selection was performed in the 
same manner for all proteins in the 58 mcSEED subsystems/pathway modules. Representative 
proteins from the fecal meta-proteomes were queried against representative proteins from these 
mcSEED subsystems/pathway modules using DIAMOND (51) with the threshold for best hits set 
to ≥80% identity. As a result of this mapping, all members of a given cluster of microbiome-
encoded proteins were assigned the best-hit annotation of the representative mcSEED protein.  
 A sparse RF-derived model was built using the aggregated mcSEED subsystem/pathway 
module abundances for all fecal samples collected from 10 healthy Bangladeshi children who had 
been sampled monthly from birth to 2 years of age. Applying this model to a separate test set of 
20 healthy children sampled at 6, 12, 18, and 24 months of age gave a prediction of functional 
microbiome age. A smoothing spline function was fit between the predicted functional 
microbiome age and chronologic age of each individual at the time of fecal sample collection for 
these 20 healthy children. Limiting the model to the 30 subsystems/pathway modules with the 
highest feature importance scores did not significantly impact its accuracy. The resulting sparse 
RF-derived model explained 69.1% of the variance associated with age. The model was applied 
to a separate test set of 20 healthy Bangladeshi individuals sampled at 6, 12, 18, and 24 months of 
age. The correlation (Pearson’s r) between chronological age and functional microbiome age in 
this test set was 0.66 (P = 4.4 x 10-6), with a mean absolute error (MAE) of 3.9 months and root 
mean square error (RMSE) of 5.1 months (29.2% of the mean). 
 The sparse RF-derived model was then applied to the mcSEED subsystem/pathway module 
abundance profiles of fecal samples obtained from children with SAM prior to, during and after 
treatment. Relative functional maturity for each sample was calculated by subtracting the 
functional microbiome age of that sample from the spline fit functional microbiome age of 
samples obtained from healthy children of similar chronologic age.  
 Quantifying enteropathogen burden by multiplex qPCR – Nucleic acids were isolated from 
fecal samples and adjusted to 2ng/µL. Levels of 18 bacterial and viral pathogens and parasites 
were determined by using a microfluidic-based digital PCR system with 96.96 Dynamic Arrays 
(Fluidigm Corp. San Francisco, CA). TaqMan primers and probes (52) were used to construct the 
24 different assays employed for this analysis. cDNAs were prepared from 50 ng of total RNA 
using Life Technologies High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 
Foster City, CA). The resulting products were subjected to Specific Target Amplification (STA) 
using TaqMan PreAmp Mastermix (Applied Biosystems), 50 nM of each primer, and the 
following cycling conditions; 10 minutes at 95 °C followed by 14 cycles of 95 °C for 15 seconds 
and then 60 °C for 1 minute. At the conclusion of this step, the reaction mixture was diluted 1:4 
in low EDTA DNA suspension buffer (10 mM Tris, 0.1 mM EDTA, pH 8.0) combined with 
TaqMan Universal PCR Master Mix (Applied Biosystems) and 20X Gene Expression Sample 
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Loading Reagent (Fluidigm). Assay mixtures containing 9 µM of each primer and 2 µM of the 
probe in Dynamic Array Assay Loading Reagent (Fluidigm) (52) were loaded into appropriate 
inlets on the primed 96.96 Dynamic Array chip before it was placed on the NanoFlex-4 Integrated 
Fluidic Circuit Controller for distribution of the sample and assay mixture. The loaded Dynamic 
Array was then inserted into the BioMark™ Reverse-Transcription-PCR System. The qPCR 
program consisted of the following steps: 50 oC for 2 minutes, 95 oC for 2 minutes and 40 cycles 
of 95 oC for 15 seconds and 60 oC for 1 minute. Enteropathogen abundance was calculated by 
comparing cycle threshold to standards of known concentration, yielding absolute measurements 
of pg genomic DNA (bacterial enteropathogens and parasites), copy number (RNA viruses) and 
mass of viral DNA per lysate mass (Adenovirus). 
 
GNOTOBIOTIC MOUSE STUDIES 
All mouse experiments were performed using protocols approved by Washington University 
Animal Studies Committee. Mice were housed in plastic flexible film gnotobiotic isolators (Class 
Biologically Clean Ltd., Madison, WI) at 23oC under a strict 12-hour light cycle (lights on a 
0600h). Male germ-free C57BL/6 mice were initially weaned onto an autoclaved, low-fat, high-
plant polysaccharide chow (2018S, Envigo) that was administered ad libitum. Animals were 
maintained on this diet until 3 days prior to the beginning of experiments involving tests of the 
effects of complementary food ingredients. Using a disposable sterile gavage needle, defined 
consortia of sequenced age-discriminatory bacterial strains cultured from Bangladeshi children, 
or intact uncultured microbiota from donors with post-SAM MAM were introduced into recipient 
mice at 5 weeks of age. All animals were euthanized by cervical dislocation without prior fasting.  
 
Screen of CFCs described in fig. S2 and the monotonous feeding experiments involving the 
initial MDCF prototype and MS/KH described in Fig. 3.  
Design and preparation of diets - Bangladeshi diets were constructed using extensive knowledge 
of Bangladeshi complementary feeding practices, including quantitative 24 hour dietary recall 
surveys conducted at the Mirpur site as part of the MAL-ED study [see (53) for a description of 
methods]. All diets were prepared by Dyets, Inc. (Bethlehem, PA). The compositions and 
quantities of each ingredient used to prepare each diet are provided in table S8B,D. 
 To prepare the Mirpur-18 diet (table S8D), rice (parboiled, long grain) and red lentils 
(masoor dal) were each cooked separately with an equal weight of water at 100oC in a steam-
jacketed kettle until ‘par-cooked’ (grains cooked, but still firm) and then set aside. Fresh market 
white potatoes, spinach and yellow onions were washed, chopped in a vertical cutter mixer and 
cooked in the kettle without added water at 70oC until soft. Sweet pumpkin (Calabaza variety) 
was cut and boiled in the steam-jacketed kettle until soft, and then strained. At this point, all of 
the cooked ingredients were combined, whole bovine milk powder (Franklin Farms East, 
Bethlehem, PA), soybean oil, salt, turmeric and garlic were added and the resulting diet was 
mixed extensively. 
 To prepare the CFC diets, rice, red lentils, potato, spinach and sweet pumpkin were cooked as 
described above for Mirpur-18. Canned garbanzo chickpeas and ground peanuts were roasted 
separately in a small amount of water for 8-10 minutes and blended into a paste prior to use. 
Tilapia (frozen fillets) was placed in the kettle with a small amount of water to steam until cooked 
thoroughly (~20 minutes). Eggs were scrambled. Banana, whole milk powder and whole-wheat 
flour (atta) were not cooked. Individual CFC diets were prepared by combining their various 
components in the quantities listed in table S8B and mixed thoroughly using a planetary mixer 
prior to pelleting. 
 To generate Khichuri-Halwa, Khichuri (table S8D) was prepared by first cooking rice and 
red lentils in a steam kettle (Groen) at 100 oC with an equal weight of water until the grains were 
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cooked but still firm. White potato, spinach and yellow onions were washed and chopped in a 
vertical cutter mixer and cooked with spices in the steam kettle without added water at 70 °C until 
soft. Sweet pumpkin was cut and boiled in the kettle until soft, and then strained. Cooked 
ingredients were then combined on a weight basis in the proportions shown in table S8D. To 
prepare Halwa (table S8D), jaggery was added to the steam kettle with water and heated (70 °C) 
until it was fully dissolved, after which time cooked lentils were added. This hot mix was added 
to the bowl of a planetary mixer in which atta flour (pre-roasted for 5 minutes with a small 
amount of water) and soybean oil had been pre-mixed. The Halwa was blended extensively into a 
uniform thick paste. Milk suji was prepared by combining whole bovine milk powder, rice 
powder, sugar and soya oil along with minerals in the amounts listed in table S8D. The individual 
components (milk suji, Khichuri, and Halwa) were then combined at a ratio of 28:36:36 (to 
simulate the relative contributions of these components to dietary intake during the nutritional 
rehabilitation phase of treatment of children with SAM at Dhaka Hospital) and homogenized. 
 Once all diets had been prepared, they were spread on trays, dried overnight at 30 °C, and 
pelleted by extrusion (½” diameter; California Pellet Mill, CL5). Dried pellets were weighed into 
~250g portions, placed in a paper bag with an inner wax lining, which in turn was placed in a 
plastic bag. The material was vacuumed sealed and sterilized by gamma irradiation (30-50 kGy; 
Sterigenics, Rockaway, NJ). Sterility was assessed by culturing irradiated pellets in Brain Heart 
Infusion (BHI) broth, Nutrient broth, and Sabouraud-dextran broth (all from Difco) for one week 
at 37 °C under aerobic conditions, and in Tryptic Soy broth (Difco) under anaerobic conditions 
(atmosphere of 75% N2, 20% CO2 and 5% H2; vinyl anaerobic chambers from Coy Laboratory 
Products, Grass Lake, MI). Additionally, cultures of all diets were plated on BHI agar 
supplemented with 10% horse blood (Difco). The irradiated diet pellets were subjected to 
nutritional analysis (Nestlé Purina Analytical Laboratories; St. Louis, MO) (see table S8E for 
results). All diets were stored at -20 °C prior to use. 
 Isolation and culturing of age-discriminatory and SAM-associated bacterial strains - 
Bacterial strains were cultured from fecal samples collected from a 24-month-old child enrolled 
in the SAM study described above, and from three donors aged 6-24 months that exhibited 
healthy growth as defined by serial anthropometry. These latter three children were members of 
two previously completed Bangladeshi birth cohort studies; (i) ‘Field Studies of Amebiasis in 
Bangladesh’ (ClinicalTrials.gov identifier: NCT02734264) and (ii) ‘Interactions of Enteric 
Infections and Malnutrition and the Consequences for Child Health and Development’ 
(abbreviated ‘Malnutrition and Enteric Disease Study’ (MAL-ED) ClinicalTrials.gov identifier: 
NCT02441426)] (53, 54). Protocols for these two studies were approved by the Ethical Review 
Committee at icddr,b. Informed consent was obtained from the mother/guardian of each child. 
Collection and use of biospecimens from each of the human studies was approved by the 
Washington University Human Research Protection Office (HRPO). 
 Collections of cultured anaerobic bacterial strains were generated from frozen fecal samples 
according to previously published methods (55, 56). All procedures were performed under 
anaerobic conditions in a Coy chamber. Fecal samples (~0.1 g aliquots) were weighed, brought 
into the Coy chamber, diluted 1:10 (wt/vol) with reduced PBS (PBS/ 0.05% L-cysteine-HCl) in 
50 mL conical plastic tubes containing 5 mL of 2 mm-diameter glass beads (VWR, catalog 
number 26396-506). Tubes were gently vortexed and the resulting slurry was passed through a 
100 µm-pore diameter nylon cell strainer (BD Falcon). The clarified fecal sample was then 
combined with an equal volume of a solution of PBS/0.05% L-cysteine-HCl/30% glycerol and 
aliquoted into 1.8 mL glass vials (E-Z vials, Wheaton). Tubes were crimped with covers 
containing a PTFE/grey butyl liner (Wheaton) and stored at -80 °C. 
 Frozen stocks were brought into the Coy chamber, thawed and serially diluted over a 1000-
fold range with PBS/0.05% L-cysteine-HCl. 100 µL of each dilution were spread on agar plates 
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containing MegaMedium and 0.05% L-cysteine-HCl (55, 57). Plates were incubated at 37 °C 
under anaerobic conditions for 48 h. Single colonies were handpicked into 96-deep-well plates 
(Thermo Fisher Scientific) containing 600 µL of MegaMedium broth. Deep-well plates were 
subsequently incubated at 37 °C under anaerobic conditions for 48 h, at which time a 50 µL 
aliquot from each deep well was robotically transferred into a well of a 96-well shallow plate 
containing an equal volume of PBS/0.05% L-cysteine-HCl/30% glycerol (n=2 replicate stock 
plates; stored at -80 °C). The deep well plate with the remaining 500 µL in each well was 
removed from the Coy chamber and subjected to centrifugation (3,220 x g for 20 min at 4 °C). 
Using a liquid handling robot, the resulting supernatant was removed and DNA was extracted 
from cell pellets with phenol:chloroform. V4-16S rDNA amplicons were generated by PCR and 
sequenced (Illumina MiSeq; paired-end 250 nt reads). 
 Isolates whose V4-16S rDNA sequences shared ≥97% sequence identity with age-
discriminatory 97%ID OTUs and/or were enriched in the microbiota of children with SAM were 
selected for an additional round of colony purification. Full-length 16S rRNA gene amplicons 
were generated from these isolates using primers 8F and 1391R (58). Isolates sharing ≥99% 
nucleotide sequence identity in their full length 16S rRNA genes, and ≥96% nucleotide sequence 
identity throughout their genomes [NUCmer; (59); (see next paragraph)], were defined as unique 
strains. Taxonomy was assigned based on the full-length 16S rDNA sequences (RDP version 2.4 
classifier; table S6A). Purified, sequenced strains were each grown to mid-log phase in 
MegaMedium; stocks were then prepared (15% glycerol/MegaMedium) in crimped vials and 
stored at -80 °C. 
 Bacterial genome sequencing, assembly, annotation, in silico reconstructions and 
phenotype predictions - Barcoded, paired-end genomic libraries were prepared for each bacterial 
isolate DNA sample, and the libraries were sequenced in multiplex (Illumina MiSeq instrument; 
paired-end 150 nt or 250 nt reads). Reads were de-multiplexed and assembled using SPAdes (60) 
(table S6A,C). Contigs with greater than 10X coverage were initially annotated using Prokka 
(47). Genes in each genome were also annotated at various levels by mapping protein sequences 
to the Prokaryotic Peptide Sequence database of the Kyoto Encyclopedia of Genes and Genomes 
(KEGG, 4 March 2017 release; 1x10-5 E-value threshold for BLASTP searches; 61). 
 Subsystems-based, context-driven functional assignments of genes, curation and metabolic 
reconstructions were performed in the web-based mcSEED (microbial communities SEED) 
environment, a private clone of the publicly available SEED platform (62, 63). The mcSEED 
platform currently includes: (i) ~6,000 bacterial genomes carefully selected for phylogenetic 
diversity, including a subset of 2,300 reference mammalian gut microbial genomes representing 
690 species (64) and (ii) a collection of curated metabolic subsystems. These subsystems include 
a subset of 58 biosynthetic, salvage and utilization pathway modules for amino acids, B-vitamins 
and related cofactors, carbohydrates, central carbon metabolism and fermentation, projected over 
~200 genomes representing the cultured strains described in this report and their nearest 
phylogenetic neighbors. In silico reconstructions of selected metabolic pathways were based on 
functional gene annotation and prediction using homology-based methods supplemented by three 
genome context techniques: (i) clustering of functionally-related genes on the chromosome 
(operons) compared to closely-related annotated genomes, (ii) predicted co-regulation of genes by 
a common regulator (regulons) and (iii) co-occurrence of genes in a set of related genomes. 
Context-based techniques are particularly helpful in disambiguating paralogs with related but 
distinct functions (characteristic for sugar utilization pathways, most notably transporters and 
transcriptional regulators), filling in gaps (“missing genes”) in known pathway variants, including 
functional assignments (predictions) of previously uncharacterized protein families (e.g., non-
orthologous gene replacements), and inferring alternative biochemical routes. Initial training sets 
of transcription factor binding sites (TFBS) and co-regulated genes were taken from the 
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RegPrecise database of bacterial regulons (65). RNA regulatory elements (riboswitches) were 
determined using RibEx (66).  Note that mcSEED pathways may be more granular than a 
subsystem (e.g. uptake of a nutrient versus its metabolism). mcSEED subsystems/pathway 
modules are presented as lists of assigned genes and their annotations in table S11A. Predictions 
are presented here in the form of a Binary Phenotype Matrix with table S6D-G showing the 
supporting evidence (presence/absence of genes in a pathway). Information from the 
Carbohydrate Active Enzyme (CAZy) database (http://www.cazy.org) was integrated into the 
annotations to expand subsystem/pathway module coverage for utilization of complex 
carbohydrates. 
 COmmunity PROfiling by Sequencing (COPRO-Seq) – The effects of diet on the 
configuration of the defined consortium of cultured strains was defined by COPRO-Seq (67). 
Briefly, DNA was isolated by subjecting fecal pellets or cecal contents collected from gnotobiotic 
mice, to bead-beating for 3 minutes in a mixture containing 500 µL Buffer A (200 mM NaCl, 200 
mM Tris, 20 mM EDTA), 210 µL 20% SDS, 500 µL phenol:chloroform:isoamyl alcohol 
(25:24:1, pH 7.9), and 250 µL of 0.1 mm diameter zirconium beads (BioSpec Products). Bead-
beating was performed in 2 mL screw cap tubes (Axygen) using a Mini-Beadbeater-8 (Biospec). 
The aqueous phase was collected after centrifugation at 4 °C for 5 min at 8,000 x g. Nucleic acids 
were purified with QIAquick columns (Qiagen) and eluted with nuclease-free water (Ambion). 
COPRO-Seq libraries were prepared by first sonicating 100 µL of a 5 ng/µL solution of DNA 
from each sample [Bioruptor Pico (Diagenode, New Jersey, USA); 10 cycles of 30 seconds on / 
30 seconds off at 4 °C]. Fragmented DNA was concentrated in MinElute 96 UF PCR Purification 
plates (Qiagen). Fragments were blunt-ended, an “A”-tail was added, and the reaction products 
were ligated to Illumina paired-end sequencing adapters containing sample-specific, 8 bp in-line 
barcodes. Size selection was performed (1% agarose gels); 250-350 bp fragments were excised 
from the gel and the DNA was purified by MinElute Gel Extraction (Qiagen). Adapter-linked 
fragments were enriched by a 20-cycle PCR using Illumina PCR Primers PE 1.0 and 2.0 followed 
by treatment with the MinElute PCR Purification kit. Barcoded libraries were quantified (Qubit 
dsDNA HS kit), pooled and subjected to multiplex sequencing [Illumina NextSeq instrument, 
unidirectional 75 nt reads; 5.4x106 ± 4.7x106 reads/sample (mean ± SD); n = 162 samples]. Reads 
were demultiplexed and mapped to the reference genomes of community members, plus six 
“distractor” genomes (Lactobacillus ruminis ATCC 27782, Megasphaera elsdenii DSM 20460, 
Olsenella uli DSM 7084, Pasteurella multocida subsp. multocida str. 3480, Prevotella dentalis 
DSM 3688, and Staphylococcus saprophyticus subsp. saprophyticus ATCC 15305). The 
proportion of reads mapping to “distractor” genomes in each sample was used to set a 
conservative cutoff threshold (mean + 2 SD), indicating the presence/absence of an organism in 
the community on a per-sample basis. Normalized counts for each bacterial strain in each sample 
were used to produce a relative abundance table.  
 Microbial RNA-Seq – The effects of MS/KH and the initial MDCF prototype containing 
three selected complementary foods (chickpea, banana and tilapia) were tested in monotonous 
feeding experiments involving mice that had been colonized at 5 weeks of age with the defined 
consortium of 14 bacterial strains (n = 3 cages of dually-housed animals/treatment group). 
Methods used for isolation of RNA from cecal contents, processing of transcripts for microbial 
RNA-Seq, sequencing [Illumina NextSeq instrument; unidirectional 75 nt reads; 1.2x107 ± 
2.7x106 reads/sample (mean ± SD); n = 24 samples], and analysis of the resulting datasets are 
described in a previous publication (68). Briefly, sequence data were mapped to the genomes of 
community members. Raw counts were subsetted, normalized and analyzed by two 
complementary strategies. To analyze data at the community level (‘top-down’ view of the meta-
transcriptome), or to obtain a strain-level view of transcriptional responses (‘bottom-up’ 
analysis), raw read count data for each sample were filtered at a low abundance threshold of three 
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reads. An additional filter for consistent representation in biological replicates was then applied 
(present in ≥66% of samples in a given treatment group, or present in all samples in one group 
and in none of the other). The resulting dataset was then imported into R and differential 
expression analysis was performed using DESeq2 (69). 
 KEGG-annotated gene lists for each organism (or the community in aggregate) were 
processed into gene sets in R (v3.4.1; (49)), and subsequently used for complementary pathway 
enrichment analyses with the R packages clusterProfiler [v3.4.4; (70)) and GAGE (v2.26.1; (71)]. 
For hypergeometric enrichment tests, lists of differentially expressed genes were supplied to the 
clusterProfiler ‘enricher’ function along with corresponding gene set information. DESeq2-
normalized counts were supplied along with corresponding gene set information to GAGE, with 
settings to order genes by the non-parametric Wilcoxon Rank Sum statistic (“rank.test = T, 
saaTest = gs.tTest”) and to allow genes displaying both increased and decreased expression in 
each tested level of the KEGG hierarchy to be considered (“same.dir = F”). P-values were 
adjusted to control false discovery rate (Benjamini-Hochberg method). 
 Targeted Mass Spectrometry – Aliquots of cecal contents taken from the same animals used 
to compare microbial gene expression in mice monotonously fed MS/KH and the initial MDCF 
prototype, plus comparably fed germ-free controls were subjected to targeted mass spectrometry 
(n = 4 treatment groups; 3 cages of dually-housed mice/group). Quantification of targeted 
metabolites was performed by using external standards. For cecal amino acids, monosaccharides 
and disaccharides, flash frozen cecal contents were homogenized in 20 vol/wt of HPLC grade 
water. Homogenates were centrifuged (4,000 x g for 10 minutes at 4 °C). A 200 µL aliquot of 
each supernatant was combined with ice-cold methanol (400 µL). The mixture was vortexed, 
centrifuged (8,000 x g at 4  °C), and a 500 µL aliquot of the resulting supernatant was evaporated 
to dryness. Dried samples were derivatized by adding methoxylamine (80 µL of a 15 mg/mL 
stock solution prepared in pyridine) to methoximate reactive carbonyls (incubation for 16 h at 37 
°C), followed by replacement of exchangeable protons with trimethylsilyl groups using N-
methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) together with a 1% v/v catalytic 
admixture of trimethylchlorosilane (1 h incubation at 70 °C). Heptane (160 µL) was added and a 
1 µL aliquot of each derivatized sample was injected into an Agilent 7890B/5977B GC/MS 
system. 
 Tryptophan and its metabolites were quantified using an ion pair-based reverse phase (IP-RP) 
chromatographic method. Chromatographic separation was achieved using an Agilent ZORBAX 
Extend C18 RRHD 2.1 x150 mm, 1.8 µm column with the ion-pairing agent tributylamine added 
to the mobile phases. A Model 1290 Infinity II UHPLC quaternary pump was coupled to an 
Agilent 6470 Triple Quadrupole LC/MS system equipped with a Jet Stream electrospray 
ionization source. dMRM (dynamic multiple reaction monitoring) parameters including 
precursor, product ions and retention times were determined using chemical standards. 
MassHunter Optimizer Software was used to determine optimal collision energies and fragmentor 
voltages for each metabolite. The protocol for GC-MS of short chain fatty acids is described in a 
previous publication (56). 
 To measure amino acids, acylcarnitines, organic acids and acylCoAs in liver, gastrocnemius 
muscle and serum, samples were weighed while frozen and homogenized in 50% acetonitrile 
containing 0.3% formic acid (50 mg wet weight tissue/mL solution) using a high-speed 
homogenizer (IKA, catalog number EW-04739-21) set at maximum speed for 30 seconds. Amino 
acid and acylcarnitine measurements were made by flow injection tandem mass spectrometry, 
and with specific internal standards (36, 37). Data were acquired using a Waters AcquityTM 
UPLC system equipped with a triple quadrupole detector and a data system controlled by 
MassLynx 4.1 OS (Waters, Milford, MA). Organic acids were quantified using Trace Ultra GC 
coupled to ISQ MS operating under Xcalibur 2.2 (Thermo Fisher Scientific, Austin, TX) (38). 
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AcylCoAs were extracted, purified, and analyzed by flow injection using positive electrospray 
ionization on a Xevo TQ-S triple quadrupole mass spectrometer (Waters, Milford, MA) (39). 
Heptadecanoyl CoA was employed as an internal standard (40). 
 Western blot analysis of IGF-1 pathway components in liver - Liver proteins were isolated, 
quantified, separated by electrophoresis (4-20% gradient SDS-polyacrylamide gels) and subjected 
to Western blotting (72). The same amount of total protein was analyzed from each liver sample. 
The following primary antibodies, all generated in rabbits except for anti-Akt(pan), were 
purchased from Cell Signaling Technology: anti-phospho-AMPKα(Thr172) [catalog number 
2531], anti-Akt(pan) [catalog number 2920], anti-phospho-Akt(Ser473) [catalog number 4060], 
anti-Jak2 [catalog number 3230], anti-phospho-Jak2(Tyr1007/1008) [catalog number 3776], anti-
mTOR [catalog number 2983], anti-phospho-mTOR(Ser2448) [catalog number 5536], anti-Stat 5 
[catalog number 9363], and anti-phospho-Stat 5(Tyr694) [catalog number 9351]. Primary 
antibodies were incubated with Western blots overnight at 4 °C in a solution of Tris-buffered 
saline containing 0.1% Tween-20 (TBST) plus 1% (vol/vol) non-fat milk, followed by addition of 
secondary antibodies against rabbit or mouse immunoglobulins and a 1 h incubation at room 
temperature in TBST/1% nonfat milk. Protein bands were detected by chemiluminescence 
(Western Lightning® Plus-ECL, PerkinElmer) using the LI COR Odyssey® FC imaging system, 
and quantified by densitometry. The amount of phosphorylated protein was normalized to the 
total amount of the protein or to GAPDH. 
 Micro-computed tomography (µCT) of bone - Femurs were harvested from mice at the time 
of euthanasia and soft tissue was removed. Bones were fixed for 24 hours in 70% ethanol and 
stored at 4 °C prior to scanning. Micro-computed tomography was performed using a µCT 40 
desktop cone-beam instrument (ScanCO Medical, Brüttisellen, Switzerland). For cortical bone 
analysis, 100-200 slices were taken for each sample in the transverse plane with a 6 µm voxel 
size (high resolution); slices began at the midpoint of the femur and extended distally. For 
trabecular scans, 600 to 700 slices were taken beginning at the proximal end of the growth plate 
and moving along the femur until no further trabeculae were observed. Boundaries of, and 
thresholds for bone were drawn manually using µCT 40 software. Volumetric parameters (bone 
volume/tissue volume, bone mineral density and cortical thickness) were calculated using custom 
scripts. 
 IGF-1 ELISA - IGF-1 levels were measured in mouse serum samples using the R&D 
Systems DuoSet ELISA kit according to the manufacturer’s instructions. Samples were diluted 
1:100 in Reagent Diluent and assayed in duplicate. Optical density was quantified (BioTek 
Synergy 2 plate reader) and the resulting data were analyzed with GraphPad Prism software 
(version 7.00 for Mac). 
 
Screening 16 plant-derived complementary food ingredients in gnotobiotic mice (fig. S4) 
We generated 48 diets by supplementing the Mirpur-18 base diet with 16 different plant-based 
ingredients at three different concentrations (table S13A). We also prepared diets in which three 
of the 16 complementary food ingredients (chickpea, peanut and soybean) were incorporated as 
‘flours’ to compare the effects of raw versus processed forms (the levels of each of these flours 
were matched to the protein content of the corresponding unprocessed forms). The ingredients for 
each diet were cooked, homogenized, extruded as pellets, dried, sterilized, and sterility was 
confirmed as described above. 
 Five-week-old germ-free male C57BL/6J mice were gavaged with a consortium of 20 
cultured, sequenced bacterial strains consisting of: (i) seven weaning-phase age-discriminatory 
strains from healthy Mirpur donors, (ii) five strains from a 24-month-old SAM donor, four of 
which are prominent in the first 8-11 months of postnatal life, (iii) two milk-adapted strains from 
a 6-month-old healthy Mirpur donor, (iv) three strains prevalent in the Bangladeshi children with 
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post-SAM MAM (Clostridium amygdalinum, Eggerthella lenta, Lactobacillus gasseri), and (v) 
three weaning-phase ‘growth-discriminatory’ strains recovered from the fecal microbiota of 
Malawian children (Clostridium symbiosum, Ruminococcus gnavus, Clostridium nexile) (4). In 
silico metabolic reconstructions of the predicted requirements of these cultured strains for amino 
acids and B-vitamins, plus their capacity to utilize mono- and disaccharides are presented in table 
S6D-G.  
 Colonized mice (n = 24; singly-housed in cages containing paper houses for environmental 
enrichment) were subjected to an 8-week diet oscillation. To minimize the effects of hysteresis, 
each mouse was fed a different diet every week, and no mouse was given the two forms of an 
ingredient (i.e., raw and flour forms) in consecutive weeks. Replication was achieved by 
presenting each diet four times to different mice.  
 The relative abundances of bacterial community members were determined by COPRO-Seq 
analysis of DNA isolated from fecal samples collected at the end of each week of the diet 
oscillation protocol [Illumina Nextera DNA Library Prep Kit; Illumina NextSeq instrument; 75 nt 
unidirectional reads, 2.2x106 ± 3.3x105 reads/sample (mean ± SD), n=192 samples; table S13C]. 
Eighteen strains were detected in all animals at all time points surveyed; one of the three post-
SAM MAM strains and one of the SAM-derived strains failed to colonize recipient mice (L. 
gasseri and S. constellatus, respectively; abundance <0.001%).  
 
Effects of complementary food ingredients in mice harboring a post-SAM MAM microbiota 
Fifteen different microbial communities from 12 different participants in the SAM trial, collected 
during and/or after treatment, were introduced into separate groups of 5-week-old germ-free mice 
(n=4/donor microbiota; dually-housed). Half of the animals in each recipient group were given 
Mirpur-18 without supplementation, while the other half were given a complementary food 
formulation composed of peanut, chickpea, banana, tilapia, and milk powder (PCBT diet). Ten 
days later all animals in the two groups were switched to Mirpur-18 supplemented with peanut, 
chickpea, banana, and tilapia [Mirpur(PCBT)] and maintained on that diet for 10 days (see table 
S14A for the composition of these diets). The goal was to identify those fecal microbiota samples 
that contained the greatest number of transmissible weaning-phase age-discriminatory bacterial 
taxa, and that when transplanted into mice, exhibited increases in the relative abundances of these 
targeted organisms with supplementation of the Mirpur-18 diet. Based on the results from this 
screen (table S14B), we selected a sample obtained from a donor (PS.064) at the S7 time point 
with post-SAM MAM for a follow-up gnotobiotic mouse study. A 350 mg aliquot of this frozen 
fecal sample was brought into an anaerobic Coy chamber, vortexed in PBS with glass beads, 
filtered, and the clarified sample was aliquoted into glass vials prior to storage at -80 °C as 
described above. 
 In a follow-on study, mice received an oral gavage of 100 µL sterile 1M sodium bicarbonate 
followed by 100 µL of the clarified human fecal sample. Animals were given unsupplemented 
Mirpur-18 diet, or Mirpur-18 supplemented with peanut flour [Mirpur(P)], or Mirpur-18 
supplemented with peanut flour, chickpea flour, soy flour and banana [Mirpur(PCSB)] ad libitum. 
The supplemented diets were matched for total protein content (table S15A). Age- and sex-
matched germ-free C57BL/6J mice fed the same diets served as controls (n = 5 mice/treatment 
group; group-housed).  
 Characterizing the transplanted fecal microbiome from a donor with post-SAM MAM in 
recipient gnotobiotic mice as a function of diet treatment - DNA was extracted from the cecal 
contents of each mouse in each diet treatment group, quantified (Qubit) and normalized to a 
concentration of 0.5 ng/µL. Genomic libraries were prepared from each cecal DNA sample (n = 
5/treatment group) using the Illumina Nextera XT kit in a reaction volume of 2.5 µL. Paired-end 
150 nucleotide datasets were generated for each library by multiplex sequencing with an Illumina 
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NextSeq instrument. Reads were processed, assembled, annotated, and the representation of 
mcSEED subsystems/pathway modules was determined as described above. 
 Methods used for isolation of RNA from cecal contents, processing for microbial RNA-Seq 
[Illumina NextSeq instrument; unidirectional 75 nt reads; 6.79 ± 3.35 x106 reads/sample (mean ± 
SD); 14 samples], and analysis of the resulting datasets are described in Hibberd et al. (68). Data 
were analyzed at the community level and at the strain-level for F. prausnitzii JG_BgPS064. 
Differential expression was defined using DESeq2 (69). A total of 6,390 genes were found to be 
differentially expressed in at least one pairwise comparison of the three diets. These genes were 
subjected to enrichment analysis over the 58 mcSEED subsystems/pathway modules. Of the 
differentially expressed genes with best-scoring BLAST hits (filtered to include only those 
spanning at least 90% of the query amino acid sequence) within 2313 annotated mcSEED 
genomes representing the human gut microbiome, 1099 genes (17.7%) were attributed to the 
analyzed subsystems/pathway modules. mcSEED-annotated gene lists were used to generate gene 
sets in R and subsequently employed for pathway enrichment analysis with the GAGE R package 
(v2.26.1) (71). P-values were adjusted to control false discovery rate (Benjamini-Hochberg 
method).  
 Histochemical and immunohistochemical analysis – Immediately after euthanasia, the entire 
length of the small intestine was removed from each animal and evenly divided into proximal (SI-
1), middle (SI-2), and distal (SI-3) segments. Each of these small intestinal segments was further 
subdivided into thirds yielding three subsegments. The most proximal third sub-segment was 
placed in Carnoy’s fixative. The middle third sub-segment was perfused with and embedded in 
Optimal Cutting Temperature (OCT) compound (Tissue-Tek) and then snap frozen in a methanol-
dry ice bath. The distal third sub-segment was snap frozen in liquid nitrogen. Frozen samples 
were stored at -80oC.  
 The proximal third of each subsegment was transferred from Carnoy’s fixative into 70% 
ethanol and embedded in paraffin. Five micron-thick sections were prepared and stained with 
hematoxylin and eosin. OCT embedded blocks of the middle third sub-segments obtained from 
SI-1, SI-2, and SI-3 were sectioned at 5 µm thickness onto charged, uncoated glass slides 
(Superfrost Plus) in a cryostat at -20 °C. Following cryosectioning, slides were stained for 15 
minutes at room temperature with Safranin O and Alcian Blue pH 2.5 (Abcam) to identify nuclei 
and mucosa-associated bacteria, acidic mucopolysaccharides, and glycoproteins. Slides were then 
dehydrated with graded alcohols (Richard-Allan Scientific), rinsed with xylenes, and stored at 
room temperature in an airtight container with desiccant for 12 to 16 hours. Fifty crypts in a 
hematoxylin and eosin-stained SI-2 subsegment were analyzed per mouse per treatment group 
(n=5 animals/group). Villus-to-crypt ratios were calculated by measuring villus and crypt lengths 
in the 10 best-oriented villus-crypt units per hematoxylin- and eosin-stained SI-2 section per 
mouse per treatment group. Goblet cell and Paneth cell numbers were scored (n=10 crypts per 
hematoxylin- and eosin-stained SI-2 section/animal). Submucosal lymphoid aggregates were 
counted and measured in sections prepared from SI-1 and SI-2. Sections were also stained with 
CD3 (Abcam, catalog number ab5690), CD20 (Thermo Fisher, catalog number PA5-16701), and 
IgA (Abcam, catalog number ab97235). A biotin-conjugated, goat anti-rabbit antibody (Jackson 
ImmunoResearch, catalog number 111-065-003, diluted 1:800 in PBS/0.1% Tween 20) was 
applied, followed by incubation with horseradish peroxidase-conjugated streptavidin (Jackson 
ImmunoResearch, catalog number 016-030-084, 1:1200) and detection with betazoid 3, 3’ 
Diaminobenzidine (Biocare Medical). Nuclei were visualized with a hematoxylin counterstain 
(Leica).  
 Laser capture microdissection (LCM) - Infrared laser capture microdissection of the small 
intestinal epithelium in a 20X field of view of a well-oriented section, prepared from the OCT-
embedded subsegment, was performed by using the Arcturus Pix Cell IIe system with Arcturus 
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CapSure Macro Caps (Applied Biosystems). RNA extraction was performed immediately after 
LCM using the Arcturus PicoPure RNA extraction kit (Applied Biosystems) and treatment with 
Baseline-ZERO DNase (Epicentre). RNA quality was checked with an Agilent Bioanalyzer 2100 
using RNA 6000 Pico Chips (Agilent).  
 All Alcian Blue-stained, mucosal-associated material present in two 20X fields of view of 
sections prepared from OCT-embedded SI-1, S1-2, and SI-3 sub-segments were subjected to 
LCM and DNA was isolated [Arcturus PicoPure DNA extraction kit (Applied Biosystems) with a 
16-h incubation in proteinase K (1 µg/µL, ThermoFischer; 65 °C)]. To quantify community 
configuration along the length of the small intestine as a function of diet, V4-16S rDNA 
amplicons were generated from these mucosal DNA samples and sequenced. The resulting OTU 
table was filtered to include only OTUs with ≥0.1% relative abundance in at least two samples, 
and then rarefied to 2,000 reads/sample. 
 RNA isolated from LCM mucosa was used to characterize the effects of diet on jejunal gene 
expression. cDNA was synthesized from 10 ng of total RNA using the ‘SMARTer Ultra Low 
Input RNA for Illumina Sequencing-HV’ kit (Clontech). Successful cDNA synthesis was verified 
using a Bioanalyzer 2100 and High Sensitivity DNA Chips (Agilent). The products were sheared 
to 200-500 bp with a Covaris AFA system. Libraries were constructed by following the Clontech 
‘adapted Nextera (Illumina) DNA sample preparation protocol for use with ‘SMARTer ultralow 
DNA kit for Illumina sequencing’. A total of 21 jejunal mucosal samples were sequenced 
[Illumina NextSeq instrument; NextSeq Series High-Output Kit; 75 nucleotide paired-end reads; 
19.8 ± 5.1 x 106 reads/sample (mean ± SD); for PS.064.S7-colonized mice, n=4 samples from 
animals consuming the unsupplemented Mirpur-18 diet, 4 samples from those fed Mirpur(P), and 
5 samples from mice treated with Mirpur(PCSB); n = 3, 2 and 3 from the corresponding groups 
of germ-free animals]. 
 Reads were aligned to the Mus musculus GRCm38.p6 genome assembly with STAR version 
2.5.3a. Gene count data were derived from the number of uniquely aligned reads by 
featureCounts from Subread version 1.4.6-p5 (48). Sequencing performance was evaluated using 
RSeQC version 2.6.2. Gene counts were imported into the R/Bioconductor package edgeR and 
normalized (weighted trimmed mean of M-values), then filtered to remove genes with less than 
one count per million from further analyses. The R/Bioconductor package limma was used to 
perform differential expression analysis, and results were filtered by FDR adjusted p-values 
≤0.05. Gene set enrichment analysis was performed and results visualized in R (packages GAGE 
and Pathview).  
 
Isolation, sequencing, and genome annotation of F. prausnitzii strain JG_BgPS064  
A cecal sample that had been obtained from a gnotobiotic mouse colonized with the PS.064.S7 
donor community and stored at -80 °C was brought into an anaerobic Coy chamber, diluted to a 
concentration of 0.35 g/5 mL in Wilkins Chalgren anaerobic broth (Oxoid, Ltd.), and the slurry 
was vortexed 3 times at 30 second intervals. Serial dilutions to 10-8 were made in Wilkins 
Chalgren broth, and aliquots (100 µL each) were plated on Wilkins Chalgren agar plates or 
YHBHI+A plates [YHBHI (73) plus 1 mL/L acetic acid], with or without antibiotics to which F. 
prausnitzii is frequently resistant [sulfamethoxazole (25 mg/L) and trimethoprim (1.25 mg/L)]. 
Plates were incubated at 37 °C for 5 days; 32 single colonies per media type (128 colonies total) 
were picked and plated in duplicate. Selection for Extremely Oxygen Sensitive (EOS) bacteria 
was performed (74). Five single colonies were picked from plates that had remained in the 
anaerobic chamber but whose corresponding oxygen-exposed plate did not exhibit any growth. 
Each colony was added to 15 µL of lysis buffer (TE containing 0.1% Triton-X100), incubated at 
95 °C for 15 min, and the solution centrifuged for 10 minutes (3,100 x g at room temperature). A 
1 µL aliquot of the supernatant was added to a 20 µL reaction mixture containing 10 µL High-
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Fidelity PCR Master Mix with HF Buffer (Phusion), 1 µL of a 10 µM solution of primer Fprau02, 
1 µL of a 10 µM solution of primer Fprau07 (75) and 7 µL of nuclease-free H2O. DNA was 
amplified (initial denaturation for 2.5 minutes at 98 °C, followed by 30 cycles of 98 °C for 10 
seconds, 67 °C for 30 seconds and 72 °C for 30 seconds, followed by extension for 5 minutes at 
72 °C). An isolate with a positive amplicon was confirmed to be F. prausnitzii by performing 
PCR with primers 8F and 1391R and sequencing of the resulting full-length 16S rDNA amplicon. 
 Genomic libraries were prepared from four replicate cultures of the colony-purified F. 
prausnitzii isolate using the DNA extraction method and the scaled-down Illumina Nextera XT 
kit described above. The resulting libraries were sequenced using an Illumina MiniSeq instrument 
(paired-end 150 nt reads). Nextera adapter sequences were trimmed (cutadapt). The isolate 
genome was assembled using SPAdes (60), initially annotated using Prokka (47) and then 
subjected to in silico metabolic reconstructions.  
 
GNOTOBIOTIC PIGLET STUDIES 
Experiments involving gnotobiotic piglets were performed under the supervision of a veterinarian 
using protocols approved by the Washington University Animal Studies Committee. 
 Preparation of diets – MDCF(PCSB) and MDCF(CS) were produced using ingredients 
described in table S18A. Diets were packed in vacuum-sealed plastic bags (2 kg double-bagged 
aliquots), sterilized by gamma-irradiation (20-50 kGy) and stored at –20 oC. 
 Re-deriving piglets as germ-free – The protocol used for generating germ-free piglets was 
based on our previous publication (27) with several modifications. A pregnant domestic sow 
(mixture of Landrace and Yorkshire genetic backgrounds) that had been artificially inseminated 
(Duroc breed domestic boar), was delivered one day prior to the date of farrow (i.e., on day 113 
of gestation). The sow was sedated with ketamine (20 mg/kg, administrated intramuscularly) and 
anesthetized with isofluorane (2-3%, delivered by mask). The paralumbar abdominal area was 
disinfected with povidone-iodine. A local incisional block was achieved using 60-80 mL of 2% 
lidocaine (subcutaneous injection). Each horn of the bicornate uterus was opened and each piglet 
was removed from its amniochorionic sac while it was still located in the opened uterine horn. 
The umbilical cord was tied off and each piglet was passed immediately, prior to its first breath, 
into and through a sterile tank filled with 2% chlorhexidine (10 second procedure) to prevent 
contamination with residual viable microbes that might be present on the sow’s skin. The tank 
was connected to a sterile, flexible film ‘nursery’ isolator so that the piglets could be directly 
passed into this temporary housing unit. After the Caesarean section, the sow was euthanized 
according to American Veterinary Medical Association (AVMA) guidelines.   
 Piglets were revived in the isolator and kept on a heated pad until the remaining piglets in the 
litter were delivered. Within 24 h, all piglets were transferred from nursery isolators to larger 
gnotobiotic isolator tubs (Class Biologically Clean Ltd., Madison, WI). Before colonization on 
postnatal day 4 (see below), the germ-free status of piglets was confirmed by aerobic and 
anaerobic culture of rectal swabs in LYBHI medium (73) before colonization on postnatal day 4. 
Piglets were group-housed (4 piglets per isolator, with equivalent size range between groups, 
complying with USDA animal housing regulations). Isolators were maintained at 95-100 °F for 
the first 7-10 postnatal days, and gradually decreased to 85-90 °F as the thermoregulatory 
capacity of the animals improved.  
 Feeding protocol - Piglets were initially bottle-fed with an irradiated sow’s milk replacement 
(Soweena Litter Life, Merrick; catalog number C30287N) that was prepared in 120 g vacuum-
sealed sterilized packets (gamma-irradiated with >20 kGy) and reconstituted as a liquid solution 
in the gnotobiotic isolator (120 g/ L autoclaved water). Piglets were fed at 3-hour intervals for the 
first 3 postnatal days, at 4-hour intervals from postnatal days 4 to 10, and at 6-hour intervals from 
postnatal day 10 to the end of the experiment. Introduction of solid foods commenced at postnatal 
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day 4 and weaning was accomplished by day 14. Each gnotobiotic isolator was equipped with 
five stainless steel bowls. During the first three days after birth, all five bowls were filled with 
Soweena. From days 4 to 7, at each feeding, one bowl was filled with an MDCF prototype while 
the remaining four bowls were filled with Soweena. On day 8, one bowl of milk was replaced 
with a bowl of water. On day 9, another bowl of milk was replaced with water (i.e., each isolator 
at each feed contained 2 bowls of water, 2 bowls of Soweena and 1 bowl of MDCF). On day 10, 
each feed consisted of placement of one bowl of Soweena, two bowls of water, and two bowls of 
MDCF into the isolator. From day 11 to day 13, only one bowl was provided with Soweena, and 
the amount of milk added was reduced by one half each day during this period. On day 14, the 
last bowl of milk was replaced with a bowl of water, thereby completing the weaning 
process. Health status was evaluated every three to four hours throughout the day and night 
during weaning. After weaning, three bowls of fresh sterilized water and two bowls of fresh 
MDCF were introduced into each isolator every 6 hours to enable ad libitum feeding. MDCF 
consumption was monitored by noting the amount of input food required to fill each bowl during 
a 24-hour period. Piglets were weighed daily using a sling (catalog number 887600; Premier Inc., 
Charlotte, NC). Environmental enrichment was provided within the isolators including plastic 
balls for ‘rooting’ activity and rubber hoses and stainless steel toys for chewing and manipulating. 
The behavior and health status of the piglets were monitored every day throughout the experiment 
to ensure their well-being.  
 Colonizing piglets – Bacterial strains were cultured under anaerobic conditions in pre-
reduced MegaMedium (55, 57). An equivalent mixture of each age-/growth-discriminatory strain 
was prepared by adjusting the volumes of each culture based on optical density (600 nm) 
readings. An equal volume of pre-reduced PBS containing 30% glycerol was added to the 
mixture and aliquots were frozen and stored at -80 °C until use. Each piglet received an 
intragastric gavage (Kendall KangarooTM 2.7 mm diameter feeding tube; catalog number 
8888260406; Covidien, Minneapolis, MN) of 11 mL of a solution containing a mixture of the 
bacterial consortium and Soweena (1:10 v/v).  
 Euthanasia and biospecimen collection - Piglets were fasted for 6 hours, removed from their 
gnotobiotic isolator, sedated with ketamine (20 mg/kg, administered intramuscularly) and 
anesthetized with isofluorane (2%, delivered by mask). Euthanasia was performed on 
experimental day 31 following AVMA guidelines. Blood was collected from the heart after the 
piglets were anesthetized but prior to administration of pentobarbital. Serum was recovered from 
clotted blood samples after centrifugation (4000 x g, 10 minutes, 4 °C). Luminal contents were 
harvested from the distal 5% of the small intestine (ileum), cecum, and distal 10 cm of the colon 
and flash frozen in liquid nitrogen.	Samples of the biceps femoris and liver were placed in liquid 
nitrogen and stored at -80 °C. The left femur was also obtained at the time of euthanasia; after 
removing soft tissue and muscle, the bone was wrapped in sterile PBS-soaked gauze and stored at 
-20 °C.  
 Micro-computed tomography - Femoral bone was analyzed with a VivaCT 40 instrument 
(settings 70kVp/114 µΑ with 300 ms of integration time). The voxel dimension for the scan was 
25 µm3. The epiphyseal plate was used as a 0% reference point. Slices [2274 ± 22 per femur 
(mean ± SD)] obtained between 40 to 50% of the length of the bone were used for cortical bone 
analysis (76). Images were analyzed using a custom MatLab script based on the 3-D structural 
measuring method (77). 
 LC-MS/MS-based serum proteomics – The protein concentration of each serum sample was 
quantified [bicinchoninic acid (BCA) assay, Pierce]. An aliquot containing 500 µg of protein was 
diluted to 5 µg/µL with 100 mM ammonium bicarbonate (ABC) buffer to a total volume of 100 
µL. Samples were further diluted with 100 µL ABC buffer containing 8% sodium deoxycholate 
(SDC) plus 10 mM dithiothreitol (DTT), pH 8.0, and incubated at 90 °C for 5 minutes. Cysteines 
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were alkylated/blocked with 15 mM iodoacetamide followed by incubation at room temperature 
for 20 minutes in the dark. Samples were then loaded onto a 10 kDa MWCO spin filter 
(Vivaspin500; Sartorius) and centrifuged at 10,000 x g for 20 minutes to concentrate proteins 
atop the filter. Concentrated proteins were washed with 400 µL ABC buffer, the filter was 
centrifuged, and proteins were resuspended in 200 µL of ABC buffer containing 10 µg of 
sequencing-grade trypsin (Sigma Aldrich). Proteolytic digestion atop the filter membrane was 
allowed to proceed for 4 hours at 37 °C followed by a second application of trypsin (10 µg in 200 
µL ABC buffer; overnight incubation). Sample filters were transferred to new 2 mL microfuge 
tubes and centrifuged at 10,000 x g for 20 minutes to collect tryptic peptides in the flow-though. 
Peptide samples were acidified with 0.5% formic acid and the resulting sodium deoxycholate 
precipitate was removed by ethyl acetate extraction (78). The peptide-containing aqueous phase 
was concentrated in a SpeedVac and peptide concentrations were measured by BCA assay.  
 Peptide samples were analyzed by automated 2D LC-MS/MS using a Vanquish UHPLC with 
autosampler plumbed directly in-line with a Q Exactive Plus mass spectrometer (Thermo 
Scientific) outfitted with a triphasic back column [RP-SCX-RP; reversed-phase (5 µm Kinetex 
C18) and strong-cation exchange (5 µm Luna SCX) chromatographic resins, Phenomenex] 
coupled to an in-house pulled nanospray emitter packed with 30 cm Kinetex C18 resin. For each 
sample, peptides (5 µg) were auto-loaded, desalted, separated and analyzed across two successive 
salt cuts of ammonium acetate (50 and 500 mM), each followed by a 105-minute organic gradient 
(79). Eluting peptides were measured and sequenced by data-dependent acquisition on the Q 
Exactive instrument.  
 MS/MS spectra were searched with MyriMatch v.2.2 (80) against the Sus scrofa proteome 
(derived from genome assembly 11.1, GCA_000003025.6, January 2017) concatenated with 
common protein contaminants. Reversed-sequence entries were also provided to estimate FDR. 
Peptide-spectrum matches (PSM) were required to be fully tryptic with any number of missed 
cleavages; a static carbamidomethylation of cysteines (+57.0214 Da) and variable modifications 
of oxidation (+15.9949 Da) on methionine. PSMs were filtered using IDPicker v.3.0 (81) with an 
experiment-wide FDR controlled at < 1% at the peptide-level. Peptide intensities were assessed 
by chromatographic area-under-the-curve (label-free quantification option in IDPicker). To 
remove cases of extreme sequence redundancy, the Sus scrofa proteome was clustered at 90% 
sequence identity (UCLUST) (82), and peptide intensities were summed to their respective 
protein groups/seeds to estimate overall protein abundance. Protein abundance distributions were 
then log-transformed, normalized across samples (LOESS and mean-centered), and missing 




The plasma proteomes of children with SAM prior to and after treatment with conventional 
therapeutic foods 
Analysis of the proteomic dataset revealed significant correlations between plasma proteins and 
anthropometric indices (see table S3A for p-values). WHZ scores were positively correlated with 
circulating levels of the soluble proteolytic cleavage product of the membrane-bound growth 
hormone receptor [GHR, also known as growth hormone binding protein (GHBP), r = 0.6]. 
Approximately 50% of GH is bound to GHBP, which serves to prolong its half-life and modulate 
its biological activity (83). GHBP is increased in obese adults and reduced after weight loss (84). 
In the children treated for SAM, plasma GHBP was also positively correlated with the adipokine 
leptin (Spearman r=0.6), consistent with the notion that increased fat mass, driven by nutritional 
recovery, leads to changes in leptin and GH signaling. WHZ scores were also positively 
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correlated with downstream GH-responsive biomarkers, including lumican, extracellular matrix 
protein 1 (ECM1) and fibronectin (85).  
 A number of plasma proteins exhibited strong negative correlations with WHZ scores, 
including angiotensinogen (AGT; Spearman r = -0.70), a key component of the renin-angiotensin 
system (RAS) that regulates blood pressure and other aspects of cardio-metabolic function. 
Malnutrition has been reported to induce a pro-inflammatory state with increased expression of 
RAS components, analogous to responses observed in mouse models of diet-induced obesity (86). 
There was also an inverse correlation between plasma levels of C-reactive protein (CRP), an 
acute phase reactant and biomarker of systemic inflammation, and WHZ scores (Spearman r = -
0.56).  
 Plasma proteins with significant correlations with plasma NEFA, ketones, lactate, glucose, 
triglycerides, branched-chain amino acids and C3 acylcarnitine are listed in table S3B. They 
include growth differentiation factor 15/macrophage inhibitory cytokine -1 (GDF15/MIC-1), 
which was significantly correlated with NEFA (r=0.78) and ketones (r=0.58), and negatively 
correlated with WAZ (r = -0.69; table S3A). This TGF-b superfamily member is implicated in 
anorexia and muscle wasting associated with cancer (87), and with chronic heart failure in 
children (88).  
 Circulating IGFs (IGF-1 and IGF-2) are complexed with binding proteins (IGFBPs), 
primarily IGFBP-3. Binding to IGFBPs affects the half-life of IGFs and their interactions with 
extracellular matrix components and cell surface receptors (89). The IGFBPs have unique 
functions and are regulated in distinct ways. Unlike IGFBP-3, IGFBP-1 and IGFBP-2 are 
suppressed by GH and are implicated in adaptive changes in glucose and lipid metabolism (90). 
Pappalysin-1 (pregnancy-associated plasma protein-A, PAPP-A) is a metalloprotease that 
selectively cleaves IGFBP-2, -4, and -5, resulting in release of sequestered IGF, thereby 
promoting its ability to bind to its receptor (91). In mice, overexpression of PAPP-A in 
osteoblasts results in a marked increase in the rate of bone formation (92), while overexpression 
in muscle increases skeletal muscle weight and fiber area (93). Stanniocalcin-1 (STC1) is a potent 
physiological inhibitor of IGFBP proteolysis by PAPP-A (94). Transgenic mice engineered to 
overexpress STC1 exhibit severely reduced growth (95).  
 In children treated for SAM, levels of IGFBP-1 and IGFBP-2 were positively correlated with 
levels of NEFA (r = 0.74 and 0.68, respectively) and ketones (r = 0.49 and 0.60) while IGFBP-3 
exhibited an inverse relationship with both analytes (r = -0.62 and -0.52), and IGFBP-4 with 
ketones (r = -0.56) [table S3B]. IGFBP-4, another regulatory component of the GH-IGF axis 
positively correlated with WHZ, is highly expressed in adipocytes and is a proposed regulator of 
adipose tissue development and maintenance (96). PAPP-A was positively correlated with levels 
of branched-chain amino acids (valine r = 0.59, leucine/isoleucine r = 0.50). STC1 was strongly 
positively correlated with NEFA (r = 0.70) and negatively correlated with ponderal growth 
(WAZ; r = -0.48). In summary, these results reveal that elevated plasma levels of IGFBP-1 and 
IGFBP-2 are associated with the acutely malnourished state, whereas IGFBP-3 and IGFBP-4 are 
associated with the metabolic normalization and ponderal growth that characterize the recovery 
phase of treatment. The observed changes in PAPP-A, together with reciprocal changes in its 
physiological inhibitor, STC1, may serve to regulate IGF-1 bioavailability, thereby affecting a 
range of anabolic processes (97). 
 Correlations between abundances of age-discriminatory taxa and plasma proteins –  
We calculated Spearman’s rank correlations between (i) the abundance of OTUs identified at 
enrollment (time point S1 in Fig. 1A), at discharge (S5) and 6 months following discharge (S11), 
and (ii) levels of plasma proteins at the corresponding time points (see table S3C for all OTU-
plasma protein correlations >0.5 or <-0.5). Integrating the plasma proteomics dataset with 
changes in the relative abundances of OTUs allowed us to identify statistically significant 
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correlations between age- and growth-discriminatory bacterial taxa and mediators of host 
biological state/functions (table S3C). For example, Faecalibacterium prausnitzii (OTU 514940), 
the taxon with the highest feature importance score in the sparse RF-derived model of microbiota 
maturation in healthy members of the Mirpur birth cohort (2), exhibited strong positive 
correlations with a number of proteins involved in or regulated by GH signaling, including GHR, 
lumican, fibronectin, and ECM1 (table S3C). Multiple age-discriminatory OTUs had significant 
negative correlations with GDF15, including F. prausnitzii, Clostridiales sp., Dorea longicatena, 
Dorea formicigenerans, Blautia sp., Eubacterium desmolans, and two members of 
Ruminococcaceae (Ruminococcaceae sp. and R. torques). F. prausnitzii and a number of other 
age-discriminatory strains were also significantly negatively correlated with plasma CRP levels 
(table S3C). 
 Bifidobacterium longum is a dominant member of the microbiota of breastfed infants; its 
presence is associated with numerous beneficial effects on the gut barrier and immune function 
(98). B. longum (OTU 559527) has the third highest feature importance in the sparse Bangladeshi 
RF-derived model and is a key component of the 15-member network of co-varying bacterial taxa 
(‘ecogroup’) described in (31). It is also responsive to MDCF formulations containing the four 
lead complementary food ingredients tested in gnotobiotic mice and piglets as well as in children 
with MAM (fig. S7B in this report and Fig. 3 in (31)).  
 B. longum OTU 559527 was significantly correlated with 114 plasma proteins—the greatest 
number of significant correlations among the age-discriminatory OTUs (table S3C). These 
proteins are involved in a wide range of biological processes. The two most strongly correlated 
proteins, legumain (an asparaginyl endopeptidase) and matrix metalloproteinase-2 (MMP-
2/gelatinase A) which is proteolytically cleaved and activated by legumain, are involved in 
remodeling the extracellular matrix. Among its other functions, MMP2 has been shown to cleave 
the chemokine CCL7 (MCP-3), converting it from a leukocyte chemoattractant to an antagonist, 
reducing cell infiltration, and dampening inflammation (99). Plasma levels of three cadherins (2, 
3 and 6) that function as calcium-dependent cell adhesion molecules were positively correlated 
with B. longum abundance. 
 B. longum was also correlated with plasma levels of WNT1-inducible-signaling pathway 
protein 3 (WISP-3), a member of the CCN family of secreted proteins that regulate cell 
proliferation/survival, migration and adhesion, and differentiation in connective tissues. WISP-3 
is secreted by chondrocytes where it can act in an autocrine fashion to induce collagen and 
aggrecan production and promote expression of superoxide dismutase (100). WISP-3 contains an 
IGFBP-like motif and has been demonstrated to modulate IGF-1 signaling in breast cancer (101).  
 B. longum was positively correlated with plasma levels of CDON (cell adhesion molecule-
related/down-regulated by oncogenes). CDON and BOC (Brother of CDON) promote Hedgehog 
signaling through calcium-dependent interactions with Hedgehog ligands as co-receptors on the 
surface of target cells (102). There is considerable cross-talk between the Hedgehog pathway and 
Notch, WNT, EGF, FGF, TGF-beta and BMP signaling cascades. A number of these pathways 
are prominently represented by proteins that show significant correlations with the abundance of 
B. longum (table S3C), including positive correlations with jagged-2 (JAG2), a Notch ligand 
involved in hematopoiesis, and BMP6, which is involved in growth of bone and cartilage (103). 
Another Notch ligand, delta-like protein 4 (DLL4), exhibits a strong negative correlation with B. 
longum. Inflammation has been reported to upregulate DLL4 in endothelial cells. In conjunction 
with IL-6 (which is also negatively correlated with B. longum), DLL4 promotes differentiation of 
blood monocytes into proinflammatory M1 macrophages (104). Blockade of DLL4 produces a 
marked reduction in inflammatory T cell responses and associated tissue damage (105). 
 In the SAM study, plasma levels of TNFSF15/TL1A (tumor necrosis factor ligand 
superfamily member 15) were inversely correlated with B. longum abundance. TNFSF15/TL1A 
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is a member of the TNF superfamily that binds to death domain receptor 3 (DR3, TNFRSF25), 
activates NF-κB, and co-stimulates IFN-γ production in T cells (106). TNFSF15/TL1A and DR3 
expression are increased in T cells and macrophages in the gut mucosa of patients with 
inflammatory bowel disease (107).  
 Biomarkers of systemic inflammation are a hallmark of children with undernutrition and 
growth faltering (108). F. prausnitzii (OTU 514940, 514523, 370287), D. formicigenerans 
(1076587), a weaning-phase Bifidobacterium sp. (484304), and Ruminococcus gnavus (360015) 
were all negatively correlated with C-reactive protein (CRP). Other acute phase proteins were 
also negatively correlated with the abundance of F. prausnitzii OTUs, including serum amyloid 
A-1 protein (SAA1) and complement C2. These opsonins target microbes for clearance and aid in 
the recruitment of immune cells to sites of infection. The negative correlation between these 
proteins and F. prausnitzii, D. formicigenerans, R. gnavus and the OTU ranked second in feature 
importance (1078587; Clostridiales sp.) in the sparse RF-derived model of microbiota maturation 
suggests that (i) a deficiency of these weaning-phase taxa may be conducive to developing or 
sustaining a state of local and systemic inflammation in children with SAM, and/or (ii) such a 
state reduces their fitness. A causal role for F. prausnitzii in suppressing gut inflammation is 
supported by the finding that it produces anti-inflammatory compounds that have protective 
effects in mouse models of DNBS- and DSS-induced colitis through inhibition of the NF-κB 
pathway (109, 110). 
 MMP12 is a macrophage-specific metalloelastase whose expression was strongly correlated 
with the abundance of F. prausnitzii and several other age-discriminatory taxa including 
Clostridiales sp., D. formicigenerans, Blautia sp. and R. torques. MMP12 binding to the IκBα 
promoter is essential for transcriptional up-regulation of IκBα, which is required for IFNα 
secretion by leukocytes and antiviral immunity. Outside of the cell, MMP12 cleavage also forms 
a feedback loop to down-regulate IFNα by degrading it, thereby limiting systemic effects of 
prolonged IFNα elevation (111). A similar negative feedback role has been described for 
macrophage MMP12 in the proteolysis and inactivation of pro-inflammatory CXC and CC 
cytokines released by LPS stimulation of polymorphonuclear leukocytes (112). 
 Plasma levels of heat shock proteins Hsp90aa1 and Hsp90ab1 were strongly negatively 
correlated with F. prausnitzii levels in the gut microbiota. The observed relationship between F. 
prausnitzii and Hsp90 in plasma suggest that there is an extracellular or secreted form of Hsp90. 
There is a growing appreciation of the role of extracellular heat shock proteins as ‘danger’ signals 
that stimulate innate and adaptive immune responses (113-115).  
 
Microbial RNA-Seq analysis of the effects of the initial MDCF prototype versus Milk-Suji/ 
Khichuri-Halwa (MS/KH) in gnotobiotic mice colonized with the defined community 
To further characterize the responses of the 14-member consortium of age-discriminatory 
bacterial strains to the initial MDCF prototype, 5-week-old germ-free C57Bl/6J mice (n = 6 
animals/treatment group; 3 cages of dually-housed mice/group) were placed on MDCF or MS/KH 
and three days later gavaged with the 14-member consortium. All mice were monotonously fed 
their designated diets for an additional 40 days. There were no significant differences in microbial 
community biomass [2.9±0.8 µg DNA/g cecal contents (MDCF) versus 2.7±0.3 µg/g (MS/KH); 
p=0.48, Mann-Whitney test]. COPRO-Seq analysis disclosed that as in the previous experiment 
shown in Fig. 3, the weaning-phase age-discriminatory strains R. torques, R. obeum, F. praunitzii 
and D. longicatena exhibited the largest and most statistically significant elevations in their 
relative abundances in the ceca of MDCF- compared to MS/KH-fed mice (Mann-Whitney test; 
table S9C).  
 Microbial RNA-Seq datasets were generated from cecal contents and the results were 
interpreted based on KEGG and SEED-based annotations of the 40,735 predicted protein-coding 
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genes present in consortium members, plus in silico predictions of the abilities of the bacterial 
strains to produce, utilize and/or share nutrients (tables S6D,E, table S11).  
 Three weaning-phase age-discriminatory strains -  F. prausnitzii, R. obeum and R. torques - 
had the greatest number of genes with statistically significant differences in their expression 
between the two diets [320, 308 and 184, respectively; table S11C(i)). Given its high feature 
importance scores in the Bangladeshi and other RF-derived models of microbiota development 
(see table S4B,C and (31)), its consistent increase in fitness with MDCF compared to MS/KH 
across experiments, its multiple predicted nutrient requirements (table S6D,E), and the large 
number of genes that are differentially expressed between the two diets, F. praunitzii represents 
an attractive ‘model’ for investigating how the MDCF prototype affects weaning-phase age-
discriminatory microbial targets. 
 Among the F. prausnitzii genes with significantly higher levels of expression in the ceca of 
mice fed MDCF versus MS/KH were an alpha-glucosidase belonging to CAZyme glycoside 
hydrolase family (GH) 31 (EC:3.2.1.20; encoded by FPSSTS7063_00084), a GH 13 oligo-1,6-
glucosidase (EC:3.2.1.10; FPSSTS7063_00083), a glycosyltransferase (GT) family 35 
starch/glycogen phosphorylase (EC:2.4.1.1; FPSSTS7063_00079), and three linked genes in the 
maltose/maltodextrin transport system (FPSSTS7063_00085-87) (table S11A). Increased 
expression of F. prausnitzii genes encoding enzymes that hydrolyze 1,4- and 1,6-alpha-glucosidic 
linkages suggests that starch serves as a preferred substrate. In contrast, R. torques exhibits 
increased expression of the agaEFG-rafA genes involved in uptake and hydrolysis of alpha-
galactosides such as raffinose (RTSSTS7063_01731-01735) (table S11A); this pathway is absent 
from F. prausnitzii. These differentially expressed genes might reflect adaptations to chickpea 
and banana, two of the three complementary food leads represented in the initial MCDF 
prototype; both complementary foods are rich in raffinose and stachyose while banana is also 
enriched in resistant starch (116, 117). In contrast, a set of 20 F. prausnitzii genes represented in 
several predicted operons involved in utilization of hexuronates (D-glucuronic and D-
galacturonic acids) exhibit 2- to 23-fold lower levels of expression in mice fed the MDCF diet 
compared to MS/KH (table S11A). These latter findings are consistent with observed differences 
in the availability of these nutrients in the cecum (e.g., glucuronic acid is present at lower levels 
in germ-free mice fed MDCF versus MS/KH; table S10A). 
 
Effects of diet in mice colonized with a post-SAM MAM donor microbial community 
 Microbial RNA-Seq analysis of the cecal community - The mcSEED categories ‘Amino 
Acid Metabolism’, ‘Vitamin and Cofactor Metabolism’, ‘Carbohydrate Utilization’, and 
‘Fermentation Products’ and their subsystems/pathway modules were assigned ranks, calculated 
by dividing the total number of differentially expressed genes in a category/subsystem/pathway 
module by the total number of genes in that category/subsystem/pathway module. Higher rank 
corresponds to a greater proportion of differentially expressed genes in that 
category/subsystem/pathway module. The results (Fig. 4B, table S15D,E) disclosed ‘Amino Acid 
Metabolism’ as the category with highest rank. Eighteen of the 20 subsystems/pathway modules 
belonging to this category, including all of the biosynthetic subsystems/pathway modules, were 
upregulated in mice consuming Mirpur(PCSB) or Mirpur(P) compared to Mirpur-18; the most 
upregulated subsystem/pathway module was ‘isoleucine, leucine, valine biosynthesis’ (60 genes 
significantly upregulated, and 4 significantly downregulated with Mirpur(PCSB) versus Mirpur-
18; P-values based on gene set enrichment analysis). This subsystem/pathway module was also 
the most upregulated on Mirpur(P) compared to Mirpur-18 (27 genes compared to zero 
downregulated).  
 Metabolic features of the cecal community - Targeted mass spectrometry of cecal contents 
disclosed that levels of all 15 free amino acids measured were significantly higher in colonized 
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mice consuming the unsupplemented compared to supplemented Mirpur-18 diets. These 
differences were not observed in their germ-free counterparts (see fig. S5A and table S15B; the 
latter also includes data on the levels of products of microbial metabolism of aromatic amino 
acids, carbohydrates, short chain fatty acids and B vitamins). The origin of these colonization-
dependent effects on cecal amino acid levels is unknown; for example, higher levels of free 
amino acids in the unsupplemented Mirpur-18 could reflect a more active proteolysis of dietary 
proteins or less active salvage/degradation of amino acids by the microbial community. However, 
the results are consistent with the observed differential expression patterns; i.e., accumulation of 
amino acids typically leads to repression of bacterial regulons controlling their biosynthesis. Diet-
associated differences in levels of cecal branched-chain and other amino acids in colonized 
animals were not accompanied by significant differences in levels of the corresponding serum 
amino acids (table S16).  
 The effects of MDCFs on expressed functions of a F. prausnitzii strain recovered from the 
transplanted post-SAM MAM microbiota - F. prausnitzii OTU 514940 was a prominent member 
of the cecal microbiota in these mice (15-17% mean relative abundance across the different diets; 
Fig. 4C and table S15C(ii)). We cultured and sequenced the genome of an isolate representing 
this OTU from the transplanted post-SAM MAM donor community. Strain JG_BgPS064 contains 
2,824 predicted genes; it shares 2268 genes with the SSTS_Bg7063 isolate used for the diet 
oscillation screens of complementary foods in gnotobiotic mice (table S6F). Of the 266 genes 
involved in the metabolic reconstructions described for SSTS_Bg7063, there are 248 orthologs in 
JG_BgPS064; the 19 missing genes are predicted to be non-essential for their respective 
metabolic pathways because for each there is an iso-functional paralog or alternative pathway. 
The JG_BgPS064 strain is predicted to produce all amino acids except His and Trp (although its 
genome contains committed His and Trp salvage ABC transporters). In contrast to the 
SSTS_Bg7063 strain, this isolate possesses intact LeuC-LeuD genes involved in leucine 
biosynthesis and thus is likely a Leu prototroph. Metabolic reconstructions suggest JG_BgPS064 
can utilize galactose and beta-galactosides, glucose and beta-glucosides, maltose and 
maltodextrin, fructose and fructooligosaccharides, sialic acids, N-acetylgalactosamine, hexuronic 
acids (glucoronate, galacturonate), lacto-N-biose (only galactose moiety), and 
rhamnogalacturonides (only glucoronate moiety). Additionally, this isolate possesses 
fermentative pathways for production of butyrate, formate, and acetate.  
 We mapped reads from the microbial RNA-Seq dataset onto its sequenced genome to identify 
the effects of diet on expression of genes belonging to various mcSEED categories and 
subsystems/pathway modules (table S15F). Among the 271 differentially expressed genes, the 
largest number belong to the mcSEED category ‘Amino Acid Metabolism’ (35 genes), followed 
by ‘Carbohydrate Utilization’ (18 genes). All 35 differentially regulated genes involved in amino 
acid metabolism exhibited increased expression in the supplemented compared to 
unsupplemented Mirpur-18 diet treatment groups, with the most significantly upregulated 
subsystem/pathway module being ‘isoleucine, leucine, valine biosynthesis’ and ‘glutamate 
biosynthesis’. No significant differences in expression of these pathways were observed between 
the two supplemented diets (table S15F). 
 Mass spectrometry of cecal contents from germ-free and colonized mice revealed microbiota- 
and diet-dependent effects on butyrate and acetate levels (significantly greater in colonized mice 
consuming the supplemented diets; fig. S5B and table S15B). Cecal butyrate was also positively 
correlated with the relative abundance of F. prausnitzii (Pearson r = 0.68, p=0.0074). Acetate 
production has been linked to resistance to certain enteropathogens (118), while butyrate is an 
important contributor to gut mucosal barrier function (119) (See the maintext for a discussion of 
how RNA-Seq analysis of laser capture microdissected small intestinal (jejunal) mucosa provided 
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evidence for microbiota- and diet-dependent increases expression of genes involved in barrier 
function).  
 Effects on gut cell populations - The different diets produced no statistically significant 
differences in the number of small intestinal goblet cells or Paneth cells, or crypt depth to villus 
height ratios between mice colonized with the post-SAM MAM donor microbiota (Student’s t-
test). However, analysis of hematoxylin- and eosin-stained sections revealed a trend toward an 
increase in the number and size of submucosal lymphoid aggregates in the proximal and middle 
thirds of the small intestine in post-SAM MAM microbiota colonized animals consuming 
Mirpur(PCSB) compared to the other treatment groups (fig. S6A). Immunostaining disclosed that 
these aggregates are B-cell dominant, with T-cell zones and associated rare IgA-positive plasma 
cells (fig. S6B). The number and size of these submucosal lymphoid aggregates in Mirpur(PCSB) 
treated mice harboring the post-SAM MAM microbiota was not significantly different from the 
number and size of aggregates in conventionally-raised mice harboring a native mouse microbiota 
fed a standard mouse chow (Kruskal-Wallis test with Dunn’s correction for multiple 
comparisons; fig. S6A).  
 
Microbial RNA-Seq and mass spectrometry of cecal contents from gnotobiotic piglets 
Comparative microbial RNA-Seq of cecal contents harvested from piglets consuming MDCF(CS) 
or MDCF(PCSB) diets identified 2,021 differentially expressed genes with a complex distribution 
over 12 strains (table S18C,D); 117 of these genes, from eight strains, mapped to mcSEED 
categories and associated subsystems/pathway modules.  
 Table S19A compares amino acid, mono- and disaccharide, organic acid, and short chain 
fatty acid levels in the ceca of piglets as a function of diet. Of the 24 carbohydrates measured, 
only fructose exhibited a significant difference between the two groups [higher in MDCF(PCSB)-
treated animals; P = 0.02, unpaired t-test]. MDCF(PCSB) consumption was associated with lower 
cecal lactate and pyruvate levels (P = 0.06 and 0.002, respectively), in concert with marked 
increases in the late TCA cycle intermediates malate and fumarate (P = 0.0002 and 0.005, 
respectively), but not early intermediates (citrate, succinate, and a-ketoglutarate). These findings 
are consistent with a decrease in glycolytic metabolism of glucose and an increase in oxidative 
metabolism of glucose and other fuels (table S19A).  
 
Quantitative proteomic and metabolomic analyses of serum from gnotobiotic piglets 
Because the aptamers used for quantitative proteomics analysis of human plasma samples do not 
have reported specificities for the corresponding porcine protein orthologs, we used mass 
spectrometry to compare the serum proteomes of piglets. Blood was obtained from animals after 
the 6-hour fast, just prior to euthanasia. We did not attempt to deplete serum samples of abundant 
proteins prior to two-dimensional LC-MS/MS to avoid introducing biases in our analysis. Thirty-
eight of the 398 detected proteins exhibited significant differences in their abundances between 
the two diet treatment groups (table S20).  
 Serum levels of EFEMP1 (fibulin-like extracellular matrix protein 1) in piglets consuming 
MDCF(PCSB) were 4.6-fold higher than in their MDCF(CS) fed counterparts (Fig. 5E, table 
S20). Genome-wide association studies have identified EFEMP1 as significantly associated with 
height in children (121). Mice with engineered deficiency of Efemp1 exhibit significant 
reductions in body mass and bone density (122).  
  Three other serum proteins that were significantly increased in MDCF(PCSB)-treated piglets 
are orthologs of human proteins significantly correlated with anthropometric and/or metabolic 
features in the SAM study: serpin family A member 5 (SERPINA5), complement factor I (CFI) 
and fetuin-B (FETUB) (Fig. 5E, table S20). In children recovering from SAM, levels of 
SERPINA5 were positively correlated with plasma C3-acylcarnitine, a marker of branched-chain 
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amino acid oxidation (Spearman r = 0.52) (table S3B). While circulating serum levels of amino 
acids in piglets were comparable in the two treatment groups (with the exception of Trp and Met 
which were increased in the MDCF(PCSB) group; table S19B), serum C3-acylcarnitine 
concentrations were significantly higher in the faster growing MDCF(PCSB)-treated animals than 
in those consuming MDCF(CS) (Fig. 5F). In the human study, plasma levels of fetuin-B, a 
member of the cystatin family of cysteine protease inhibitors produced by the liver, and CFI were 
positively correlated with ponderal growth [fetuin-B, r = 0.59 (WAZ) and 0.54 (WHZ); CFI, r = 
0.44 (WAZ); table S3A]. Fetuin-B has been linked to glucose homeostasis (123) and fatty acid 
utilization (124). In addition to its correlation with anthropometric measures of growth, fetuin-B 
was also positively correlated with the relative abundance of R. gnavus (OTU 360015) and F. 
prausnitzii (OTU 514940) in fecal samples collected during the course of the SAM study [r = 
0.46 and 0.66, respectively (table S3C). Note that MDCF(PCSB) significantly augments the 
representation of R. gnavus, a growth-discriminatory bacterial species (Fig. 5D)].  
 As in humans, the pig genome encodes seven IGFBP orthologs and an ALS (acid-labile 
subunit). ALS forms a ternary complex with IGF-1 and IGFBPs, prolonging the half-life of IGF-
1, and in a rat model plays a role in growth promotion (120). IGF-1 was below the limits of 
detection in our LC-MS/MS analysis of non-depleted sera, and no significant differences were 
noted in the one IGFBP that was identified (IGFBP-2). However, levels of ALS in animals fed 











fig. S1. Comparison of the fecal microbiomes of children with healthy growth phenotypes 
and those treated for SAM. (A) Changes in representation of mcSEED subsystems/pathway 
modules in the fecal microbiomes of healthy Mirpur children (n = 30) sampled during the first 
three postnatal years. (B) Ranked feature importance of the age-discriminatory mcSEED 
subsystems/pathway modules comprising the RF-derived model of gut microbiome development 
in Mirpur infants/children with healthy growth phenotypes. The mcSEED subsystem/pathway 
module ‘lipoate biosynthesis’ had the highest feature importance score; lipoate/lipoic acid is an 
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essential cofactor of dehydrogenase enzymes including branched-chain ketoacid dehydrogenase, 
a regulator of branched-chain amino acid catabolism. The representation of subsystems/ 
metabolic pathway modules involved in amino acid metabolism (including branched-chain amino 
acids and tryptophan), B vitamin metabolism, carbohydrate metabolism and fermentation are 
important contributors to the accuracy of the model. (C) Heatmap of the changes in 
representation of the top 30 most age-discriminatory mcSEED subsystems/pathway modules in 
the fecal microbiomes of the healthy Mirpur children. (D) Relative functional maturity of the 
microbiomes of children hospitalized with SAM at enrollment, just prior to treatment, at 
discharge, and at 1-, 6-, 8- and 12-months post-discharge, calculated using the RF-derived model. 
ns, not significant; *, P<0.05; (one-way ANOVA, Tukey’s multiple comparisons test). Note that 
the statistically significant improvement in relative functional maturity at 1-month post-discharge 
compared to that at enrollment is similar to the improvement observed in MAZ (Fig. 1B). 
Moreover, there is a significant positive correlation between MAZ and relative functional 
microbiome maturity (r = 0.55, P<0.0001). However, this improvement was not sustained; there 
is no statistically significant difference in this parameter between initiation of treatment and 8- or 
12-months post-discharge (one-way ANOVA followed by Tukey’s multiple comparisons test; 
adjusted P-values = 0.077 and 0.083, respectively). (E) Differences in the representation of 
mcSEED subsystems/pathway modules in the fecal microbiomes of children prior to, during and 
after treatment for SAM compared to healthy children. Abundances of the 30 most age-
discriminatory mcSEED subsystems/pathway modules in 15 individuals treated for SAM 
compared to age-matched healthy individuals. Subsystems/pathway modules whose 
representation is significantly different between healthy and SAM children for at least three of the 
six time points are highlighted in red. Mean values ± SD are shown. *, P<0.05; **, P<0.01; ***, 





fig. S2. Diet oscillation study to identify complementary foods that selectively increase the 
relative abundances of weaning-phase age-discriminatory bacterial strains in gnotobiotic 
mice. (A) Changes in the abundances of OTUs in the developing microbiota of healthy members 
of the Mirpur birth cohort that correspond to cultured strains used to colonize gnotobiotic mice. 
Rows are arranged based on unsupervised hierarchical clustering of the strains’ temporal 
abundance profiles. Strains in red font were obtained from a 24-month-old donor with SAM. B. 
pseudocatenulatum and B. catenulatum have the same V4-16S rDNA sequences as B. breve and 
B. longum. B. longum subsp. infantis was distinguished from B. longum subsp. longum based on 
its five genomic loci encoding numerous carbohydrate active enzymes (13). (B,C) Experimental 
design for diet oscillation study. Fourteen unique complementary food combinations (CFCs) were 
designed by random sampling of 12 ingredients (panel B). The composition of these CFCs and 
their order of administration were based on the following considerations. First, every CFC 
contained six different complementary food ingredients at six different levels, one of which was 
dominant (see panel C; the size of the circle in the bubble plot indicates the relative level of the 
ingredient). In addition to these six ingredients, each CFC also contained bovine milk powder and 
soybean oil to reflect the fact that children in Mirpur with MAM or SAM are typically treated 
with therapeutic foods that contain these ingredients. The Spearman correlation coefficient 
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between the amounts of any two ingredients across all diets was minimized so that the 
abundances of targeted taxa could be clearly related to a given ingredient (table S8A). Each 
selected formulation was prepared in ways that reflected common culinary practices in Mirpur, 
processed as a homogeneous blend, extruded into pellets, and sterilized by irradiation. Second, 
each group of mice received a different weekly sequence of the different diet formulations in 
order to identify ingredient-microbe interactions that are robust to order of diet presentation (i.e., 
to avoid hysteresis effects). Third, no group of mice received a formulation dominated by a 
particular complementary food ingredient more than once during the course of the experiment, 
although a given ingredient was represented in multiple formulations at different concentrations. 
Fourth, while no two groups of mice were fed diets dominated by the same complementary food 
ingredient within the same week, replication was achieved by administering it as the dominant 
ingredient to different groups at least twice over the course of an experiment (n = 8-12 mice/diet). 
Shotgun sequencing (COPRO-Seq) of total DNA isolated from fecal samples collected on the last 
day of each 1-week diet block was used to determine the relative abundance of each community 
member (see table S9A). Fourteen of the 16 cultured isolates successfully colonized all animals. 
Streptococcus gordonii and Streptococcus salivarius were the exceptions: they were below the 
limit of detection in fecal samples obtained at the 9 time points surveyed per mouse; their 
corresponding OTUs have feature importance scores of 30 and 23, respectively, in the sparse 30 
OTU Bangladeshi RF-derived model of normal gut community development. (D) Hierarchical 
clustering of Spearman’s rank correlation coefficients between the relative abundance of each 
bacterial strain in the fecal microbiota of recipient mice and levels of the indicated 






fig. S3. Relative abundances of OTUs corresponding to cultured age-discriminatory strains 
in the fecal microbiota of children living in Mirpur. Abundances of the indicated taxa were 
determined by V4-16S rDNA sequencing of fecal samples collected monthly from healthy 
children in the birth cohort (mean values ± SD are shown) and from children with SAM prior to 
treatment. Note that 29 of these 38 children were enrolled in the present study while 9 were from 
a prior SAM cohort described in (2). Neither B. breve and B. longum, nor B. pseudocatenulatum 






fig. S4. Effects of supplementing the Mirpur-18 diet with 16 plant-derived complementary 
food ingredients in mice colonized with an 18-member consortium of age-/growth-
discriminatory bacterial strains. (A) Experimental design. The diagram portrays the three 
different doses of each complementary food ingredient (colored according to the key) added to 
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the base Mirpur-18 diet (grey) and the different order of presentation of the different diets to 
different mice. Each diet was given monotonously for 1 week. (B) Relative abundances of strains 
(log scale) in the fecal microbiota of mice fed three different doses of peanut flour and chickpea 
flour (see table S13C). Mean values ± SD are shown. *, P<0.05; **, P<0.01 (Kruskal-Wallis test 






fig. S5. Targeted mass spectrometry of cecal contents harvested from gnotobiotic mice 
colonized with a post-SAM MAM donor microbiota and from germ-free controls. Levels of 
amino acids (A) and short chain fatty acids (B) in animals fed unsupplemented or supplemented 
Mirpur-18 diets (see table S15B). n.d., not detected. *, P<0.05; **, P<0.01, ***, P<0.001, ****, 




fig. S6. Diet- and colonization-dependent increases in submucosal lymphoid aggregates in 
the small intestines of gnotobiotic mice. Mice colonized with the post-SAM MAM donor 
microbiota and control germ-free animals were fed unsupplemented or supplemented Mirpur-18 
diets. (A) Lymphoid aggregates present in hematoxylin- and eosin-stained sections from the 
proximal third of small intestinal segments SI-1 and SI-2 (see Fig. 4D) were counted for all mice 
in all six treatment groups (n = 5 animals/group). ‘Size’ represents the largest cross-sectional 
diameter for each aggregate in each section scored from each small intestinal segment from each 
animal. Mean values ± SD are shown. (B) Histo- and immunohistochemical characterization of a 
representative jejunal lymphoid aggregate from a representative colonized mouse fed the 
Mirpur(PCSB) diet. The upper left portion of the subpanel notes specificity of the antibodies used 
for staining the section. *, P<0.05; **, P<0.01 (Kruskal-Wallis test with Dunn's correction for 






fig. S7. Analysis of the fecal microbiota of children in the MDCF trial. (A) Quantification of 
enteropathogen burden in children before and after treatment. Results are expressed as log-
transformed pg genomic DNA (bacteria and parasites), copy number (RNA viruses), and mass 
per cell lysate mass (Adenovirus). (B) Bacterial OTUs with significant changes in their percent 
relative abundances in the fecal microbiota of children in the MDCF-2 treatment arm. Mean 
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values ± SEM are shown. *P<0.05; **, P<0.01 (paired t-test). (C) Phylogenetic tree that includes 





table S1. The effects of three therapeutic foods in 54 children with SAM subjected to a 12-
month follow-up. (A) Composition of therapeutic foods used. (B) Clinical metadata. The eight 
individuals highlighted in boldface contributed serial plasma samples for quantitative aptamer-
based proteomic analyses. 
 
table S2. Targeted mass spectrometry-based metabolic profiling of plasma samples obtained 
from children before and at two time points after treatment for SAM. 
 
table S3. Correlations between plasma protein levels, host features and bacterial OTUs in 
the fecal microbiota of participants in the SAM study. Significant Spearman correlations 
(r>0.5 or r<-0.5) between plasma protein levels and (A) anthropometry, (B) selected plasma 
metabolites (see Fig. 2) and (C) bacterial taxa.	
 
table S4. Random Forests (RF)-derived sparse 2-year model of gut microbiota development 
in healthy members of a Bangladeshi (Mirpur) birth cohort. (A) Data used to generate RF-
derived model (B) Top 60 OTUs with the highest feature importance in the RF-derived model. 
(C) Sparse 30 OTU RF-derived model generated from healthy members of the Mirpur birth 
cohort (n=25 individuals; 539 fecal samples). OTUs are ranked in descending order of their 
importance to the accuracy of the model. The x-axis plots the increase in mean-squared error 
when abundance values from each OTU are randomly permuted. The inset shows the cross-
validation curves that result from reducing the number of 97% ID OTUs used for model training. 
 
table S5. Age-discriminatory bacterial OTU abundance, microbiota maturity (MAZ), 
mcSEED subsystem/pathway module representation, and relative functional maturity of 
fecal microbiomes of Bangladeshi children with healthy growth phenotypes versus those 
with SAM prior to and following treatment. (A) Percent relative abundances of age-
discriminatory taxa (from left to right in order of feature importance in the sparse RF-derived 
model of normal microbiota maturation) in samples from children with SAM. Calculated MAZ 
scores are provided. (B) Summary of shotgun sequencing dataset. (C) Aggregate representation 
of mcSEED subsystems/pathway modules (ordered from left to right by feature importance in the 
sparse RF-derived model of normal microbiome maturation) in each fecal DNA sample, 
expressed as reads per kilobase per million reads mapped (RPKM). Relative functional 
microbiome maturity is shown for children in the SAM study and the 20 healthy children in the 
test set for the sparse RF-derived model. 
 
table S6. Bacterial strains introduced into gnotobiotic animals. (A) Bacterial strains 
highlighted in grey were cultured from the fecal microbiota of Bangladeshi donors and used for 
the diet oscillation study shown in fig. S2 and to characterize the initial MDCF prototype (Fig. 3). 
All 20 listed strains were gavaged into germ-free mice to test the effects of supplementing 
Mirpur-18 with 16 plant-derived complementary food ingredients (fig. S4). (B) The 14-member 
consortium introduced into gnotobiotic piglets. (C) Genome characteristics of bacterial strains 
cultured from the fecal microbiota of Bangladeshi donors. (D) Summary of in silico predictions 
of the ability of the 14 age-discriminatory strains, introduced into mice in the experiments 
described in fig. S2 and Fig. 3, to produce amino acids, utilize mono- and disaccharides, and 
generate short chain fatty acids. Results are summarized in the form of a binary phenotype 
matrix. In the case of amino acids, “1” denotes a predicted prototroph and “0” an auxotroph as 
inferred from in silico reconstruction of the respective pathway (subsystem/pathway module) in 
	 40 
the analyzed genomes. In the case of carbohydrates, ‘1’ and ‘0’ refer to a strain’s predicted ability 
or inability, respectively, to utilize the indicated mono- or disaccharide while ‘1*’ indicates that 
the catabolic pathway is present but no specific transporter was identified. Binary phenotypes for 
fermentation end products are related to a strain’s predicted ability to produce the indicated 
compound. Amino acids are shown using standard 3-letter code. Abbreviations for carbohydrates: 
(Ara)n, Arabinosides; (GlcA)n, Glucuronides; (Mal)n, Maltodextrin; (Xyl)n, Xylosides; Aga, 
Alpha-galactosides; Ara, Arabinose; Bga, Beta-galactosides; Bgl, Beta-glucosides; Chb, 
Chitobiose; ddGlcA, unsaturated glucuronate; FOS, Fructooligosaccharides; Fru, Fructose; Fuc, 
Fucose; Gal, Galactose; GalA, Galacturonate; GalN, Galactosamine; GalNAc, N-
Acetylgalactosamine; Glc, Glucose; GlcA, Glucuronate; GlcNAc, N-Acetylglucosamine; Gnt, 
Gluconate; Hyl, Hyaluronate; Ino, Inositol; Lac, Lactose; Lnb, Galacto-N-biose; ManNAc, N-
Acetylmannosamine; Mel, Melibiose; Mtl, Mannitol; NANa, Sialic acids; Raf, Raffinose; Rha, 
Rhamnose; Rhi, Rhamnogalacturonides; Rib, Ribose; Scr, Sucrose; Srt, Sorbitol; Tag, Tagatose; 
Tre, Trehalose; Xlt, Xylitol; and Xyl, Xylose. (E) Details of metabolic reconstructions. (i) 
Carbohydrate metabolic pathways. (ii) Fermentation pathways. (iii) Amino acid metabolic 
pathways. (iv) Central carbon metabolic pathways. (F) Comparison of the genomes and 
metabolic reconstructions of the different F. prausnitzii strains used in these experiments. (G) 
Metabolic reconstructions for bacterial strains introduced into gnotobiotic piglets. 
  
table S7. 16S rDNA dataset and associated metadata for 38 children from Mirpur with 
SAM sampled prior to treatment (see fig. S3) 
 
table S8. Composition of diets administered to gnotobiotic mice in the initial in vivo screen 
of CFCs (see fig. S2). (A) Pairwise testing for collinearity between food ingredients in CFCs. (B) 
Ingredient composition of CFCs. (C) Nutrient content of CFC diets calculated from the USDA 
database. (D) Components of additional diets. (E) Direct nutritional analysis of diets. 
 
table S9. COPRO-Seq datasets from experiments involving gnotobiotic mice colonized with 
the defined consortium of age-discriminatory strains. (A) In vivo screen involving diet 
oscillation with various CFCs. Percent relative abundances of strains in fecal microbiota (see fig. 
S2). (B) Percent relative abundances of strains in the cecal microbiota of mice monotonously fed 
the initial MDCF prototype versus Milk Suji/Khichuri-Halwa (MS/KH) (see Fig. 3). (C) Percent 
relative abundances of strains in the cecal microbial community of mice monotonously fed the 
MDCF prototype versus MS/KH in a repeat experiment (see Supplementary Results).  
 
table S10. Diet- and colonization-dependent effects on levels of cecal metabolites in mice 
colonized with the defined consortium of age-discriminatory strains and monotonously fed 
the initial MDCF prototype versus Milk Suji/Khichuri-Halwa (MS/KH) (see Fig. 3). (A) 
Carbohydrates. (B) Short-chain fatty acids. (C) Amino acids. (D) Aromatic amino acid 
metabolites. 
 
table S11. Differentially expressed genes in cecal contents of gnotobiotic mice colonized with 
the 14-member community and monotonously fed the initial MDCF prototype or Milk 
Suji/Khichuri-Halwa (MS/KH). (A) Genes in mcSEED-based metabolic reconstructions and 
their corresponding DESeq2-normalized expression data. (B) Genes not encompassed by the 
mcSEED subsystems/pathway modules and their corresponding DESeq2-normalized 
expression. (C) Gene set enrichment analysis of KEGG pathways whose expression changes 
significantly as a function of diet treatment. 
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table S12. Diet- and colonization-dependent effects on levels of host metabolites (see Fig. 3). 
(A) Amino acids in serum. (B) Amino acids in liver. (C) Amino acids in gastrocnemius muscle. 
(D) Acylcarnitines in serum. (E) Acylcarnitines in liver. (F) Acylcarnitines in gastrocnemius 
muscle. (G) AcylCoAs in liver. (H) Organic acids in liver. (I) Conventional metabolites in serum. 
 
table S13. Testing 16 plant-derived complementary food ingredients in gnotobiotic mice 
colonized with an 18-member consortium of age- and growth-discriminatory bacterial taxa. 
(A) Composition of diets used in the screen. (B) Protein quality of the 16 plant-derived CF 
ingredients, and the number of weaning-phase age-discriminatory taxa whose abundances were 
promoted by each ingredient. (C) COPRO-Seq analysis of the effects of complementary food 
ingredients on the percent relative abundances of consortium members. 
 
table S14. A screen of the effects of complementary food ingredients on age-discriminatory 
strains present in 15 intact uncultured microbiota samples from children enrolled in the 
SAM study. (A) Composition of diets used to screen the microbiota after transplantation into 
gnotobiotic mice. (B) V4-16S rDNA-based analysis of the representation of 30 age- and 3 
growth-discriminatory taxa in groups of gnotobiotic mice harboring one of 15 different 
transplanted microbiota samples tested, as a function of diet treatment, including the number of 
age-discriminatory taxa detected and overall transplantation efficiency.   
 
table S15. Microbial responses in gnotobiotic mice colonized with a representative post-
SAM MAM donor microbiota and fed the Mirpur-18 diet with or without complementary 
food supplementation. (A) Composition of the three diets. (B) Targeted MS analysis of amino 
acids, aromatic amino acid metabolites, mono- and disaccharides, short-chain fatty acids, and B 
vitamins in cecal contents recovered from germ-free and colonized mice as a function of their diet 
treatment. (C) V4-16S rDNA analyses of (i) the biogeography of community structure associated 
with mucosa harvested by laser capture microdissection (LCM) from different small intestinal 
segments, and (ii) fecal microbiota (collected at 21 days post-gavage, dpg), and cecal microbiota 
(dpg 25), as a function of diet treatment. Age-/growth-discriminatory taxa are shown in boldface. 
(D) Abundance (RPKM) of the 30 most age-discriminatory mcSEED subsystems/pathway 
modules represented in the cecal microbiomes of mice subjected to the three different diet 
treatments. (E) Microbial RNA-Seq analysis of genes in mcSEED subsystems/pathway modules 
that exhibit significant diet-associated differences in their expression in the cecal microbiomes of 
colonized gnotobiotic mice subjected to the different diet treatments. (F) Subsystems/pathway 
modules and associated genes in the F. prausnitzii JG_BgPS064 genome that exhibit significant 
differences in their expression in the cecal microbiomes of colonized gnotobiotic mice subjected 
to the different diet treatments.  
 
table S16. Targeted MS analysis of amino acids in the sera of germ-free mice and mice 
colonized with a post-SAM MAM donor microbiota as a function of their diet treatment.  
 
table S17. RNA-Seq analysis of laser capture microdissected small intestinal mucosa, 
harvested from gnotobiotic mice, as a function of diet and colonization status. (A) 
Differentially expressed pathways in different diet contexts in mice colonized with the post-SAM 
MAM donor microbiota and in germ-free controls. (B) All differentially expressed genes in one 
or more group comparisons. 
 
table S18. The effects of two MDCF formulations on the structure and expressed functions 
of a 14-member consortium of age-/growth-discriminatory bacterial strains in gnotobiotic 
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piglets. (A) Composition of MDCF(PCSB) and MDCF(CS) compared to other diets. (B) 
COPRO-Seq analysis of community structure along the length of the gut. (C) Microbial RNA-
Seq analysis of the cecal meta-transcriptome.  
table S19. The effects of two MDCF formulations on the metabolic features of gnotobiotic 
piglets colonized with the 14-member consortium of age-/growth-discriminatory bacterial 
strains. (A) Levels of amino acids, carbohydrates, organic acids and short-chain fatty acids in the 
cecal contents of piglets treated with the two MDCF prototypes. (B) Levels of conventional 
metabolites, amino acids and tryptophan and tryptophan-related metabolites in serum. 
table S20. Mass spectrometry-based proteomic analysis of sera obtained from piglets 
treated with the two MDCF prototypes. 
table S21. Clinical data from the MDCF trial in children with MAM. (A) Organoleptic 
acceptability of the four diets tested. (B) MDCF/RUSF consumption during the trial. (C) Dietary 
diversity at baseline and at the end of the study. (D) Incidence of morbidities during the trial. (E) 
Anthropometry. (F) Enteropathogen load in children with primary MAM studied in the MDCF 
trial, healthy controls, and those with SAM. Summary statistics are shown by MDCF trial 
treatment arm or by group (healthy or SAM). 
table S22. Metadata associated with fecal and plasma samples collected from children in the 
MDCF trial, healthy controls and children with SAM.  
table S23. Plasma proteome analysis of healthy versus SAM children, and the response of 
children with primary MAM to MDCFs. (A) Plasma proteins with significant differences in 
their abundances in healthy children compared to those with SAM. The top 50 proteins whose 
levels were significantly higher in healthy individuals are highlighted in green. The top 50 
proteins significantly higher in individuals with SAM are highlighted in red. (B) Plasma proteins 
with significant fold-changes in abundance from beginning to end of treatment in the four arms of 
the MDCF trial. (C) Gene Ontology Pathways whose representation in the plasma proteome of 
children in the MDCF-2 treatment arm changes significantly (ranked in order of statistical 
significance of enrichment as determined by SetRank). 
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